<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/528E44D9-BB41-4FB4-B870-A420A440EDBF"><gtr:id>528E44D9-BB41-4FB4-B870-A420A440EDBF</gtr:id><gtr:name>Sakhalin State University</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7A468659-CE74-4F8F-91FB-F14404250B19"><gtr:id>7A468659-CE74-4F8F-91FB-F14404250B19</gtr:id><gtr:name>University of Athens</gtr:name><gtr:address><gtr:line1>Panepistimiopolis</gtr:line1><gtr:line4>Athens</gtr:line4><gtr:line5>157 71</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Greece</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9A42FA32-87CB-461C-8DB7-9064771DD1D6"><gtr:id>9A42FA32-87CB-461C-8DB7-9064771DD1D6</gtr:id><gtr:name>Ataxia UK</gtr:name><gtr:address><gtr:line1>Lincoln House</gtr:line1><gtr:line2>Kennington Park</gtr:line2><gtr:line3>1-3 Brixton Road</gtr:line3><gtr:postCode>SW9 6DE</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2493173D-13F6-44C1-B923-B6C6ABF357C0"><gtr:id>2493173D-13F6-44C1-B923-B6C6ABF357C0</gtr:id><gtr:name>University of Tehran</gtr:name><gtr:address><gtr:line1>16 Azar Street</gtr:line1><gtr:line2>Enghelab Ave</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4A179E2C-FB5E-4836-AA80-6301F4DD5AB6"><gtr:id>4A179E2C-FB5E-4836-AA80-6301F4DD5AB6</gtr:id><gtr:name>University of Sydney</gtr:name><gtr:address><gtr:line1>University of Sydney</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/90D89AF1-B099-4AD3-AF5B-00C648062DC2"><gtr:id>90D89AF1-B099-4AD3-AF5B-00C648062DC2</gtr:id><gtr:name>National Organization for Rare Disorders (NORD)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/91C308E2-1EBA-4CC1-8183-0371468DE15E"><gtr:id>91C308E2-1EBA-4CC1-8183-0371468DE15E</gtr:id><gtr:name>Wayne State University</gtr:name><gtr:address><gtr:line1>Detroit</gtr:line1><gtr:line2>Michigan</gtr:line2><gtr:line3>MI 48202</gtr:line3><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/6F0E9705-31FF-4C65-9BEC-AAC5156FB56D"><gtr:id>6F0E9705-31FF-4C65-9BEC-AAC5156FB56D</gtr:id><gtr:name>British Medical Association (BMA)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D7A9497E-C70A-4959-A29E-A16EB801E857"><gtr:id>D7A9497E-C70A-4959-A29E-A16EB801E857</gtr:id><gtr:name>Sanford Heart Hospital</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0407B94D-DABF-4B46-B5F0-2CBDC1C63C67"><gtr:id>0407B94D-DABF-4B46-B5F0-2CBDC1C63C67</gtr:id><gtr:name>national Institute on Aging</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/47977EA7-B9F8-4D02-9BD2-FD4D34F2644D"><gtr:id>47977EA7-B9F8-4D02-9BD2-FD4D34F2644D</gtr:id><gtr:name>Genomics England</gtr:name><gtr:address><gtr:line1>Queen Mary University of London</gtr:line1><gtr:line2>Dawson Hall</gtr:line2><gtr:line3>Charterhouse Square</gtr:line3><gtr:postCode>EC1M 6BQ</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3B1E5961-8677-4A32-B15C-12FB968FA163"><gtr:id>3B1E5961-8677-4A32-B15C-12FB968FA163</gtr:id><gtr:name>University of Pennsylvania</gtr:name><gtr:address><gtr:line1>3451 Walnut Street,</gtr:line1><gtr:line2>Suite P-221</gtr:line2><gtr:line3>Franklin Building</gtr:line3><gtr:line4>Philadelphia</gtr:line4><gtr:postCode>PA 19104</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DAEB2B76-3CE2-4F67-BE52-859227BD2B8F"><gtr:id>DAEB2B76-3CE2-4F67-BE52-859227BD2B8F</gtr:id><gtr:name>Great Ormond Street Hospital (GOSH)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A8B346A4-B170-4B93-86F0-EAFAC0A94BCC"><gtr:id>A8B346A4-B170-4B93-86F0-EAFAC0A94BCC</gtr:id><gtr:name>University of Thessaly</gtr:name><gtr:address><gtr:line1>Argonafton &amp; Filellinon</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F7BE6197-72FC-41EB-99F4-738055C2C57B"><gtr:id>F7BE6197-72FC-41EB-99F4-738055C2C57B</gtr:id><gtr:name>Sarah Matheson Trust for MSA</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3CCE6BCD-27BA-45CA-B5B0-5890F9F9B4F9"><gtr:id>3CCE6BCD-27BA-45CA-B5B0-5890F9F9B4F9</gtr:id><gtr:name>Partnership for Advanced Computing in Europe (PRACE)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339"><gtr:id>EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339</gtr:id><gtr:name>European Commission</gtr:name><gtr:address><gtr:line1>Wetstraat 200 / Rue de la Loi 200</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/89D5574C-AAF7-4D96-832C-C2BA623123CE"><gtr:id>89D5574C-AAF7-4D96-832C-C2BA623123CE</gtr:id><gtr:name>Eberhard Karls University Tuebingen</gtr:name><gtr:address><gtr:line1>Wilhelmstra?e 7</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Institute of Neurology</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/528E44D9-BB41-4FB4-B870-A420A440EDBF"><gtr:id>528E44D9-BB41-4FB4-B870-A420A440EDBF</gtr:id><gtr:name>Sakhalin State University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7A468659-CE74-4F8F-91FB-F14404250B19"><gtr:id>7A468659-CE74-4F8F-91FB-F14404250B19</gtr:id><gtr:name>University of Athens</gtr:name><gtr:address><gtr:line1>Panepistimiopolis</gtr:line1><gtr:line4>Athens</gtr:line4><gtr:line5>157 71</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Greece</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9A42FA32-87CB-461C-8DB7-9064771DD1D6"><gtr:id>9A42FA32-87CB-461C-8DB7-9064771DD1D6</gtr:id><gtr:name>Ataxia UK</gtr:name><gtr:address><gtr:line1>Lincoln House</gtr:line1><gtr:line2>Kennington Park</gtr:line2><gtr:line3>1-3 Brixton Road</gtr:line3><gtr:postCode>SW9 6DE</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2493173D-13F6-44C1-B923-B6C6ABF357C0"><gtr:id>2493173D-13F6-44C1-B923-B6C6ABF357C0</gtr:id><gtr:name>University of Tehran</gtr:name><gtr:address><gtr:line1>16 Azar Street</gtr:line1><gtr:line2>Enghelab Ave</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4A179E2C-FB5E-4836-AA80-6301F4DD5AB6"><gtr:id>4A179E2C-FB5E-4836-AA80-6301F4DD5AB6</gtr:id><gtr:name>University of Sydney</gtr:name><gtr:address><gtr:line1>University of Sydney</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/90D89AF1-B099-4AD3-AF5B-00C648062DC2"><gtr:id>90D89AF1-B099-4AD3-AF5B-00C648062DC2</gtr:id><gtr:name>National Organization for Rare Disorders (NORD)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/91C308E2-1EBA-4CC1-8183-0371468DE15E"><gtr:id>91C308E2-1EBA-4CC1-8183-0371468DE15E</gtr:id><gtr:name>Wayne State University</gtr:name><gtr:address><gtr:line1>Detroit</gtr:line1><gtr:line2>Michigan</gtr:line2><gtr:line3>MI 48202</gtr:line3><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6F0E9705-31FF-4C65-9BEC-AAC5156FB56D"><gtr:id>6F0E9705-31FF-4C65-9BEC-AAC5156FB56D</gtr:id><gtr:name>British Medical Association (BMA)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D7A9497E-C70A-4959-A29E-A16EB801E857"><gtr:id>D7A9497E-C70A-4959-A29E-A16EB801E857</gtr:id><gtr:name>Sanford Heart Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0407B94D-DABF-4B46-B5F0-2CBDC1C63C67"><gtr:id>0407B94D-DABF-4B46-B5F0-2CBDC1C63C67</gtr:id><gtr:name>national Institute on Aging</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/47977EA7-B9F8-4D02-9BD2-FD4D34F2644D"><gtr:id>47977EA7-B9F8-4D02-9BD2-FD4D34F2644D</gtr:id><gtr:name>Genomics England</gtr:name><gtr:address><gtr:line1>Queen Mary University of London</gtr:line1><gtr:line2>Dawson Hall</gtr:line2><gtr:line3>Charterhouse Square</gtr:line3><gtr:postCode>EC1M 6BQ</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3B1E5961-8677-4A32-B15C-12FB968FA163"><gtr:id>3B1E5961-8677-4A32-B15C-12FB968FA163</gtr:id><gtr:name>University of Pennsylvania</gtr:name><gtr:address><gtr:line1>3451 Walnut Street,</gtr:line1><gtr:line2>Suite P-221</gtr:line2><gtr:line3>Franklin Building</gtr:line3><gtr:line4>Philadelphia</gtr:line4><gtr:postCode>PA 19104</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DAEB2B76-3CE2-4F67-BE52-859227BD2B8F"><gtr:id>DAEB2B76-3CE2-4F67-BE52-859227BD2B8F</gtr:id><gtr:name>Great Ormond Street Hospital (GOSH)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A8B346A4-B170-4B93-86F0-EAFAC0A94BCC"><gtr:id>A8B346A4-B170-4B93-86F0-EAFAC0A94BCC</gtr:id><gtr:name>University of Thessaly</gtr:name><gtr:address><gtr:line1>Argonafton &amp; Filellinon</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F7BE6197-72FC-41EB-99F4-738055C2C57B"><gtr:id>F7BE6197-72FC-41EB-99F4-738055C2C57B</gtr:id><gtr:name>Sarah Matheson Trust for MSA</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3CCE6BCD-27BA-45CA-B5B0-5890F9F9B4F9"><gtr:id>3CCE6BCD-27BA-45CA-B5B0-5890F9F9B4F9</gtr:id><gtr:name>Partnership for Advanced Computing in Europe (PRACE)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339"><gtr:id>EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339</gtr:id><gtr:name>European Commission</gtr:name><gtr:address><gtr:line1>Wetstraat 200 / Rue de la Loi 200</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/89D5574C-AAF7-4D96-832C-C2BA623123CE"><gtr:id>89D5574C-AAF7-4D96-832C-C2BA623123CE</gtr:id><gtr:name>Eberhard Karls University Tuebingen</gtr:name><gtr:address><gtr:line1>Wilhelmstra?e 7</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/2761A603-5EF4-4006-8C7C-FBD7F3D90FC5"><gtr:id>2761A603-5EF4-4006-8C7C-FBD7F3D90FC5</gtr:id><gtr:firstName>John</gtr:firstName><gtr:surname>Hardy</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/002FC006-2518-458A-AB1F-FF4586FFE8D7"><gtr:id>002FC006-2518-458A-AB1F-FF4586FFE8D7</gtr:id><gtr:firstName>Michael</gtr:firstName><gtr:surname>Hanna</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/DDA7FCBE-11EA-45E5-ABEC-F9881608386E"><gtr:id>DDA7FCBE-11EA-45E5-ABEC-F9881608386E</gtr:id><gtr:firstName>David</gtr:firstName><gtr:surname>Hilton-Jones</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/C7FEA0B7-1227-4A7E-95CF-50D321AB8DCB"><gtr:id>C7FEA0B7-1227-4A7E-95CF-50D321AB8DCB</gtr:id><gtr:firstName>Henry</gtr:firstName><gtr:surname>Houlden</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MR%2FJ004758%2F1"><gtr:id>724FF539-B38A-4F56-B1D8-0BF2FD972FF2</gtr:id><gtr:title>Using Next Generation Sequencing to Unravel the Pathogenesis of Sporadic Inclusion Body Myositis - The International IBM Consortium Genetic Study</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MR/J004758/1</gtr:grantReference><gtr:abstractText>The commonest muscle disease that occurs in patients over the age of 45 years is a muscle wasting disease called inclusion body myositis (IBM). Patients typically develop progressive muscle wasting and weakness that progresses and causes marked disability and ultimately death from immobility over the course of around 10 years. There are no effective treatment for patients with IBM. The precise cause of this muscle disease is not known. However, on muscle biopsies from patients there seems to be a combination of some mild inflammation in the muscle and also an accumulation of abnormal proteins, similar to the accumulated proteins that are seen in the brains of patients with neurodegenerative diseases such as Alzheimer's, fronto-temporal dementia and motor neurone disease. 

Previous research has indicated that there may be genetic factors that predispose people to getting IBM but the previous studies have been quite small and not conclusive. In this research we have brought together experts in IBM from all over the world including Europe, USA and Australia to generate increased awareness of IBM, define diagnostic criteria, collect clinical information and DNA. Over the last three years we have been able to collect the largest group ever of IBM patients and DNA samples - approximately 950 cases and this number will be over 1000 once this study begins. The patient DNA and muscle tissue has been carefully stored for this work. This very large collection of DNA has put us in a very good position to undertake much more detailed genetic studies than have ever been done before to try and work out what the genetic risks factors and genes are that predispose people to this devastating disease.

We plan to use the latest next generation sequencing techniques to unravel all the coding variants (those that alter proteins) that are present in 200 IBM patients DNA samples in comparison with 200 patients that are controls with normal muscles. We will analyze the DNA that we have already extracted from patients muscle tissue as this is the best diagnostic group. We will replicate the variants found in a further 700 IBM cases and over 2200 other controls. We are highly experienced in next generation sequencing technology and this has been strengthened by the recent award of a Wellcome Trust equipment grant to purchase the latest next generation sequencer. Recently we have used these techniques to identify the genetic causes of other neuromuscular disorders.

In comparison with other disorders like Alzheimer's disease, where proteins are aggregated in the brain as opposed to the muscle as in IBM, the greatest advancement have been made with the identification of disease genes and genetic risk factors. If we can work out what the key genes are and how these disease causing pathways function, we will pave the way for new therapies and treatments to help patients.</gtr:abstractText><gtr:technicalSummary>1. Library preparation for exome sequencing
In each case high quality DNA (A260/280 ratio &amp;gt;1.8) has been extracted. We have switched over to the Illumina TruSeq Enrichment Kit as it allows six samples to be pooled for exome sequencing and is therefore far more cost effective. The enrichment method is a standard protocol from Illumina starting with the TruSeq sample preparation, pooling of six samples, capture of targeted regions with the TruSeq exome kit and then sequencing. The HiSeq has a very large capacity for sequencing, with the TruSeq enrichment our current most cost effective run is 100bp paired-end reads which gives 60 million reads per sample, at around 68 fold coverage (2 samples per lane). Depending on cost we can modify the runs in several ways, usually by extending read length and changing samples per lane.

2. Exome sequence data processing and variant calling
After the genome analyser generates the raw sequencing images (image analysis) there are several steps involved in the read conversion to variant calling. These include initial base calling, sequence alignment, building, indexing, sorting SAM files, recalibrating quality scores, removing duplicates and merging lanes. Variants are called and filtered based on quality control (read depth, quality scores etc). A genotype file is produced and then annotation and prediction of consequence (amino-acid change, predicted damage of variant) is carried out using the package Sorting Intolerant From Tolerant (SIFT).

3. Statistical analysis
This will primarily focus on gene level comparisons testing a reduced set of genes identified as harbouring non-synonymous coding variants or splice variants that may contribute to risk of IBM. Exome sequence data will be filtered first to remove common variants found in publicly available data from dbSNP and the 1000 Genomes Project. A second level of filtering will be used to extract non-synonymous coding variants and splice variants using existing exome annota</gtr:technicalSummary><gtr:potentialImpactText>Who will benefit
Importance and unmet health need for patients and the economy: Inclusion body myositis is the most common acquired muscle disease in patients over the age of forty years. It causes progressive major disability and often premature death after 5-10 years from the consequences of immobility. It represents a significant unmet health need in the UK-worldwide. Since onset is often in prime working life and patients often become significantly disabled quickly and cannot contribute to the economy. A systematic genetic study using the latest genetic technology has not been undertaken. Limited studies have suggested a HLA association, however the disease is unresponsive to immunosuppression and discovery of new mechanisms pathways is required. Key beneficiaries from this research include 1. The immediate and wider science communities, 2. Key established and new industry partners who can develop new paradigms for drug testing based on new genetic discovery 3. Patient organisations and patients. Until now IBM patients have been a relatively neglected group experiencing delayed and misdiagnosis. Professor Hanna and the MRC Centre for translational research have existing partnerships with the major patient organisations linked to IBM namely the myositis support group where Professor Hanna is an advisor helped plan annual patient meetings and the Muscular Dystrophy Campaign that also support IBM patient groups.

How will they benefit
Potential areas for exploitation from this research: Discovery of new genetic associations for IBM will have significant potential to build on existing collaborations with industry and develop new industry collaborations. Potential new areas arising from this research include- identification of new target pathways that might be druggable, the possibility of developing new or taking advantage of existing animal models and of developing new cellular models. All these possibilities will be of interest to industry especially for testing new therapies based on the genetic discovery of new targets. We have established collaborations with the Senexis (Cambridge biotech) to screen anti protein aggregate small molecules and we are currently using a nematode and a myoblast line for screening. However, Senexis- (see MRC Centre Senexis collaboration at www.cnmd.ac.uk) have access to very large number of potential agents- new genetic discovery could direct selection. We have an existing collaboration with Cytrx USA and completing a proof of principle heat shock protein upregulation experimental medicine study in IBM- this relationship will be developed by new genetic discovery. New IBM genetic associations has potential for new genetic testing paradigms for risk stratification and potential for commercialisation of genetic testing. 
With Patients and Patient Organisations- the MRC Centre for Neuromuscular Diseases has established effective and regular communication channels with the key patient groups representing IBM. Results of this research along with implications and impact for patients and families will be discussed at the annual Myositis Support Group meeting, the annual MRC Centre patient group meeting and the Muscular Dystrophy Campaign patient group meetings and local branch meetings. All our latest IBM research is posted on the MRC Centre website, the MDC website and the Myositis support group newsletter. With policy makers and NHS commissioners-Professor Hanna is actively engaged with the cross party parliamentary group for neuromuscular diseases including IBM and has given evidence in parliament about the impact of neuromuscular diseases including IBM and has worked with this group and the commissioners to develop standards of care for patients- this work is ongoing and can include implications of this genetic research discovery for patient care eg genetic risk assessment.</gtr:potentialImpactText><gtr:fund><gtr:end>2016-08-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2013-02-27</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>691269</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Ataxia UK</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Ataxia UK</gtr:description><gtr:id>D7C608CB-9D08-4EDF-9C60-EAD77A54E3D7</gtr:id><gtr:impact>Publications, made UK patients with Ataxia more aware</gtr:impact><gtr:outcomeId>A7FFBA7590F-1</gtr:outcomeId><gtr:partnerContribution>Made members aware of our work, identified patients and families</gtr:partnerContribution><gtr:piContribution>Information and genetic analysis of patients</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute on Aging</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Laboratory of Neurogenetics, NIA and NIH, USA</gtr:description><gtr:id>E803F0AE-CE6A-44E0-B722-80200C4EBF75</gtr:id><gtr:impact>Publications, assistance with grants</gtr:impact><gtr:outcomeId>Xs8yYa5ZzDo-2</gtr:outcomeId><gtr:partnerContribution>Sharing of data, cases and techniquesData and publications</gtr:partnerContribution><gtr:piContribution>Data, cases, publications</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Sydney</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:department>Brain and Mind Research Institute</gtr:department><gtr:description>Childhood Motor Neuron Disease consortium</gtr:description><gtr:id>89510AC3-D42B-44B8-89C2-2A9519CFE3E9</gtr:id><gtr:impact>A number of DNA samples and fibroblasts collected</gtr:impact><gtr:outcomeId>Kh4BVG8DYez-2</gtr:outcomeId><gtr:partnerContribution>Collaborators have provided clinical details, cells, DNA for exome sequencing and gene identification</gtr:partnerContribution><gtr:piContribution>Collaborative group that have collected clinical details, cells, DNA and treatment responses on Childhood Motor Neuron Disease</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Organization for Rare Disorders (NORD)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>NORD</gtr:description><gtr:id>27E073D0-964C-4AA3-AD2E-E2D24BD602CC</gtr:id><gtr:impact>Patient's referred and a grant</gtr:impact><gtr:outcomeId>nDa21vfuupd-1</gtr:outcomeId><gtr:partnerContribution>Patient's referred and a grant</gtr:partnerContribution><gtr:piContribution>Patient's referred and a grant</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>European Commission</gtr:collaboratingOrganisation><gtr:country>European Union (EU)</gtr:country><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>Neuromics FP7 collaboration</gtr:description><gtr:id>D89B62BF-9217-429C-BA40-02A2A8767299</gtr:id><gtr:impact>Publications, collaboration and preparation for other rare disease grants</gtr:impact><gtr:outcomeId>56dda6ff4d69f2.22859113-1</gtr:outcomeId><gtr:partnerContribution>Shared results and materials - genome/exome sequencing, functional data and patient materials</gtr:partnerContribution><gtr:piContribution>Neuromics FP7 collaboration where we received funding for a post-doc (to prof hanna) and also funding for sequencing.
There was significant collaboration and added value from this collaboration with shared results and materials</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Centre for Neuromuscular Diseases</gtr:department><gtr:description>MRC NMC</gtr:description><gtr:id>D25BCB92-07EF-44B9-968F-AEC78408D8D5</gtr:id><gtr:impact>I am a member of the MRC Centre for Neuromuscular Diseases which has brought in very important collaborations between myself and Mike Hanna and Mary Reilly. We have generated considerable data, patient information and publications.</gtr:impact><gtr:outcomeId>e1whaABWaoL-1</gtr:outcomeId><gtr:partnerContribution>I am a member of the MRC Centre for Neuromuscular Diseases which has brought in very important collaborations between myself and Mike Hanna and Mary Reilly. We have generated considerable data, patient information and publications.</gtr:partnerContribution><gtr:piContribution>I am a member of the MRC Centre for Neuromuscular Diseases which has brought in very important collaborations between myself and Mike Hanna and Mary Reilly. We have generated considerable data, patient information and publications.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute on Aging</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Laboratory of Neurogenetics, NIA</gtr:description><gtr:id>BA18951C-0B44-49E2-A742-6867653E69E9</gtr:id><gtr:impact>Joint publications and techniques</gtr:impact><gtr:outcomeId>107C332DC25-1</gtr:outcomeId><gtr:partnerContribution>Collaboration on techniques and patients</gtr:partnerContribution><gtr:piContribution>Collaborating on techniques such as developing DNA arrays and exome sequencing in our lab</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>European Commission</gtr:collaboratingOrganisation><gtr:country>European Union (EU)</gtr:country><gtr:department>EC FP6 Collaborative Projects</gtr:department><gtr:description>EUROSCA</gtr:description><gtr:id>931F11D4-B75F-4249-A854-184FE44DF179</gtr:id><gtr:impact>Publications as already give. Patients and clinical details of cases with ataxia</gtr:impact><gtr:outcomeId>C8022CF03BB-1</gtr:outcomeId><gtr:partnerContribution>EUROSCA is a collaboration between researchers and clinicians working on ataxia. These has brought cases and techniques that have benefited my research.</gtr:partnerContribution><gtr:piContribution>Identification, screening and functional characterization of ataxia genes</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Sarah Matheson Trust for MSA</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Sarah Matheson Trust for MSA</gtr:description><gtr:id>03B9B89D-1052-47EC-9B8E-C5435CC21B05</gtr:id><gtr:impact>Publications, Brought patients and encouraged brain donation of MSA patients for our research</gtr:impact><gtr:outcomeId>921118C1E24-1</gtr:outcomeId><gtr:partnerContribution>Brought patients and encouraged brain donation of MSA patients for our research</gtr:partnerContribution><gtr:piContribution>Brought patients and encouraged brain donation of MSA patients for our research</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Pennsylvania</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>School of Veterinary Medicine (UPenn)</gtr:department><gtr:description>PENN collaboration on Dog ataxia and neuropathy</gtr:description><gtr:id>5BA38284-A542-4210-87EF-26B6321A707A</gtr:id><gtr:impact>Joint grant submitted to NIH</gtr:impact><gtr:outcomeId>FnkjAQW7K1f-1</gtr:outcomeId><gtr:partnerContribution>Provided tissue and clinical details</gtr:partnerContribution><gtr:piContribution>PENN collaboration on Dog ataxia and neuropathy.

We are working on the genetics of neuropathy and ataxia in dog models of human disease</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Sarah Matheson Trust for MSA</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>MSA Trust</gtr:description><gtr:id>AD0D8313-56EC-4704-8DDB-51DE23F8341B</gtr:id><gtr:impact>Publications, data, tours of the lab, newsletter information</gtr:impact><gtr:outcomeId>eodK9WGCHrW-1</gtr:outcomeId><gtr:partnerContribution>Patients, we write a research update in the newletter, many patients have given blood and donated their brain as a result of the research</gtr:partnerContribution><gtr:piContribution>Data, tours of the lab, newsletter information</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Tehran</gtr:collaboratingOrganisation><gtr:country>Iran, Islamic Republic of</gtr:country><gtr:description>University of Tehran</gtr:description><gtr:id>FC1226D2-3A94-4DE9-8FCB-41ED0D566618</gtr:id><gtr:impact>Prof Elahe has provided many inportant families for our research and we currently share a PhD student</gtr:impact><gtr:outcomeId>j7X5YhDsm95-1</gtr:outcomeId><gtr:partnerContribution>Prof Elahe has provided many inportant families for our research and we currently share a PhD student</gtr:partnerContribution><gtr:piContribution>Prof Elahe has provided many inportant families for our research and we currently share a PhD student</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Genomics England</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Genomics England Genome Sequencing (100,000 genomes) and Neurology GeCIP (HH is co-lead)</gtr:description><gtr:id>612C7175-7AC0-431F-B43F-A3389F368234</gtr:id><gtr:impact>Genomics England Genome Sequencing (100,000 genomes) and Neurology GeCIP (HH is co-lead)</gtr:impact><gtr:outcomeId>56ddaab95929e7.94396092-1</gtr:outcomeId><gtr:partnerContribution>Genomics England Genome Sequencing (100,000 genomes) and Neurology GeCIP (HH is co-lead)</gtr:partnerContribution><gtr:piContribution>Genomics England Genome Sequencing (100,000 genomes) and Neurology GeCIP (HH is co-lead)</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Great Ormond Street Hospital (GOSH)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Neurology</gtr:department><gtr:description>Childhood Motor Neuron Disease consortium</gtr:description><gtr:id>66282A1C-4660-44EB-9D59-5C1FB34FA3E3</gtr:id><gtr:impact>A number of DNA samples and fibroblasts collected</gtr:impact><gtr:outcomeId>Kh4BVG8DYez-3</gtr:outcomeId><gtr:partnerContribution>Collaborators have provided clinical details, cells, DNA for exome sequencing and gene identification</gtr:partnerContribution><gtr:piContribution>Collaborative group that have collected clinical details, cells, DNA and treatment responses on Childhood Motor Neuron Disease</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Centre for Neuromuscular Diseases</gtr:department><gtr:description>MRC Centre for Neuromuscular Diseases</gtr:description><gtr:id>393A2845-79A4-4BCA-AE85-55A7410843F4</gtr:id><gtr:impact>The MRC Centre for Neuromuscular Diseases is an MRC funded centre set up to investigate the causes and identify treatments for neuromuscular diseases. I am a member and collaborator in the The MRC Centre for Neuromuscular Diseases.</gtr:impact><gtr:outcomeId>5EB6CEB5F9D-1</gtr:outcomeId><gtr:partnerContribution>The MRC Centre for Neuromuscular Diseases is an MRC funded centre set up to investigate the causes and identify treatments for neuromuscular diseases. I am a member and collaborator in the The MRC Centre for Neuromuscular Diseases.</gtr:partnerContribution><gtr:piContribution>The MRC Centre for Neuromuscular Diseases is an MRC funded centre set up to investigate the causes and identify treatments for neuromuscular diseases.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Partnership for Advanced Computing in Europe (PRACE)</gtr:collaboratingOrganisation><gtr:country>Belgium, Kingdom of</gtr:country><gtr:description>Synaptopathies consortium</gtr:description><gtr:id>4FA5D820-DBF0-4CC7-B133-5BCE81EAE46F</gtr:id><gtr:impact>Built up a significant cohort</gtr:impact><gtr:outcomeId>56dda7f8d9c511.31485830-1</gtr:outcomeId><gtr:partnerContribution>Families and samples</gtr:partnerContribution><gtr:piContribution>Synaptopathies consortium: Wellcome Trust strategic award
Sequencing in paroxysmal disorders with collaboration with Rothman, Kullmann, Hanna, Sisodiya, Goadsy and others</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Athens</gtr:collaboratingOrganisation><gtr:country>Greece, Hellenic Republic</gtr:country><gtr:department>Neurology Athens</gtr:department><gtr:description>Athens collaboration on ataxia and neuropathy</gtr:description><gtr:id>8E178DE6-642F-4205-AE4E-B325E6241115</gtr:id><gtr:impact>Large Greek study on ataxia and neuropathy in Greece</gtr:impact><gtr:outcomeId>GvFsmF4nAKm-1</gtr:outcomeId><gtr:piContribution>Large Greek study on ataxia and neuropathy in Greece</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Sanford Heart Hospital</gtr:collaboratingOrganisation><gtr:description>dystonia genetics and functional gene collaboration</gtr:description><gtr:id>D48A470B-19EF-4B0F-B397-0C0359F5027A</gtr:id><gtr:impact>DMRF joint grant</gtr:impact><gtr:outcomeId>JHUxh8CKWJY-1</gtr:outcomeId><gtr:partnerContribution>dystonia genetics and functional gene collaboration</gtr:partnerContribution><gtr:piContribution>Exome sequencing, fibroblast and expression studies</gtr:piContribution><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Athens</gtr:collaboratingOrganisation><gtr:country>Greece, Hellenic Republic</gtr:country><gtr:department>Neurology Athens</gtr:department><gtr:description>Greek Collaboration on neurogenetics - Athens, Thessaloniki and Larisa</gtr:description><gtr:id>7A0B22A2-039B-46AD-AFAB-174686954082</gtr:id><gtr:impact>Sharing of families and data</gtr:impact><gtr:outcomeId>5463d47cdc4257.17558439-1</gtr:outcomeId><gtr:partnerContribution>Greek Collaboration on neurogenetics - Athens, Thessaloniki and Larisa
Sharing of DNA and clinical details on series and families</gtr:partnerContribution><gtr:piContribution>Greek Collaboration on neurogenetics - Athens, Thessaloniki and Larisa
Sharing of DNA and clinical details on series and families</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Wayne State University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Wayne State University</gtr:description><gtr:id>2FABCE9B-0337-4E18-8E5D-B2369BB6966B</gtr:id><gtr:impact>Sharing of CMT1A patient data and DNA</gtr:impact><gtr:outcomeId>RpFVHoJATmh-1</gtr:outcomeId><gtr:partnerContribution>Sharing of CMT1A patient data and DNA</gtr:partnerContribution><gtr:piContribution>Sharing of CMT1A patient data and DNA</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC UK Brain Banks Network</gtr:department><gtr:description>European and American Brain Bank Network</gtr:description><gtr:id>7AF90A24-AEB9-4412-92A7-7CFFED04648A</gtr:id><gtr:impact>Publications and the addition of important tissue resources</gtr:impact><gtr:outcomeId>76D7752909A-1</gtr:outcomeId><gtr:partnerContribution>Collaborated with tissus</gtr:partnerContribution><gtr:piContribution>This collaboration has given valuable patient brain tissue to our research</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>British Medical Association (BMA)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>BMA</gtr:description><gtr:id>EF9A3C7E-D958-4B54-ADBE-FB2144413D3A</gtr:id><gtr:impact>Funding and publication</gtr:impact><gtr:outcomeId>nrTBYatScPi-1</gtr:outcomeId><gtr:partnerContribution>Funding and good press for our research</gtr:partnerContribution><gtr:piContribution>Funding and publication</gtr:piContribution><gtr:sector>Learned Society</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute on Aging</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Laboratory of Neurogenetics, NIA and NIH, USA</gtr:description><gtr:id>026D69C0-3E2A-4D6B-8CD6-CF2D5FAA150F</gtr:id><gtr:impact>Publications, assistance with grants</gtr:impact><gtr:outcomeId>Xs8yYa5ZzDo-1</gtr:outcomeId><gtr:partnerContribution>Sharing of data, cases and techniquesData and publications</gtr:partnerContribution><gtr:piContribution>Data, cases, publications</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Veterinary Medicine</gtr:department><gtr:description>Cambridge collaboration on Dog ataxia and neuropathy.</gtr:description><gtr:id>486B15DE-DAC8-4AE4-8C29-175CB9D7FDAA</gtr:id><gtr:impact>Ongoing work</gtr:impact><gtr:outcomeId>TiLk1mX2EBG-1</gtr:outcomeId><gtr:partnerContribution>Dog tissue</gtr:partnerContribution><gtr:piContribution>Cambridge collaboration on Dog ataxia and neuropathy.

We are working on the genetics of neuropathy and ataxia in dog models of human disease</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Sakhalin State University</gtr:collaboratingOrganisation><gtr:country>Russian Federation</gtr:country><gtr:description>Sakhalin Universitycollaboration</gtr:description><gtr:id>CAA43339-E62A-44A4-942A-DAE9E7CF6225</gtr:id><gtr:impact>ongoing</gtr:impact><gtr:outcomeId>GiKwEB27NTk-1</gtr:outcomeId><gtr:piContribution>Collaboration on patients with Neuropathy in Russia</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Thessaly</gtr:collaboratingOrganisation><gtr:country>Greece, Hellenic Republic</gtr:country><gtr:department>Neurology Thessaly</gtr:department><gtr:description>Larisa Greek parkinsonism study</gtr:description><gtr:id>93FF3E77-439E-4200-974B-AE185B13558D</gtr:id><gtr:impact>Over 1200 Greek parkinsonian patients and controls collected and DNA extracted.

Work ongoing, GWAS underway</gtr:impact><gtr:outcomeId>hSTdgtcyGvw-1</gtr:outcomeId><gtr:piContribution>Larisa Greek parkinsonism study.

Over 1200 Greek parkinsonian patients and controls collected and DNA extracted</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Pennsylvania</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Neurology</gtr:department><gtr:description>Childhood Motor Neuron Disease consortium</gtr:description><gtr:id>F74C7D14-6E5E-49B8-9BBA-BC257E32ED83</gtr:id><gtr:impact>A number of DNA samples and fibroblasts collected</gtr:impact><gtr:outcomeId>Kh4BVG8DYez-1</gtr:outcomeId><gtr:partnerContribution>Collaborators have provided clinical details, cells, DNA for exome sequencing and gene identification</gtr:partnerContribution><gtr:piContribution>Collaborative group that have collected clinical details, cells, DNA and treatment responses on Childhood Motor Neuron Disease</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC UK Brain Banks Network</gtr:department><gtr:description>European Brain Bank Network</gtr:description><gtr:id>9F91698C-8F30-4F00-AD09-FCA30F15698B</gtr:id><gtr:impact>Brain tissue for our research</gtr:impact><gtr:outcomeId>iWsvpuzpkvw-1</gtr:outcomeId><gtr:partnerContribution>Brain tissue for research</gtr:partnerContribution><gtr:piContribution>Brain tissue for our research</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Eberhard Karls University of Tubingen</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Neuromics</gtr:department><gtr:description>Neuromics neurogenetics collaboration</gtr:description><gtr:id>8924EC69-A398-4573-8E70-56493AA0E6C6</gtr:id><gtr:impact>Recently started</gtr:impact><gtr:outcomeId>ncvkmb8CSLy-1</gtr:outcomeId><gtr:partnerContribution>Groups working on several areas of genetics</gtr:partnerContribution><gtr:piContribution>We are the channelopathy and ataxia part of the collaboration. Our role is exome sequencing, genetics and expression</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>HSP society</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>464C2702-3E40-4EE0-A13D-E619D89394BB</gtr:id><gtr:impact>HSP yearly meet and section in HSP booklet</gtr:impact><gtr:outcomeId>k9hnMBBF1Tf</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012,2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Muscle Study group UK and international</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>18C1E3AF-7D45-42DA-A25E-70FDB12996F4</gtr:id><gtr:impact>Genetics and exome sequencing in Muscle Disease

Collaboration</gtr:impact><gtr:outcomeId>r2yywfogD7f</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Genomics England Genome Sequencing (100,000 genomes) and Neurology GeCIP (HH is co-lead)</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>3E13134D-D0E2-40CD-B6D2-3FC14D2579A5</gtr:id><gtr:impact>Genomics England Genome Sequencing (100,000 genomes) and Neurology GeCIP (HH is co-lead)</gtr:impact><gtr:outcomeId>56dda9db80bbe3.87510799</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.genomicsengland.co.uk</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Neuromuscular research day</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>92618ED4-C4B8-48C8-8EF0-4F174E229CEE</gtr:id><gtr:impact>Around 100 patients

More patients involved in our research</gtr:impact><gtr:outcomeId>X2LAP1Nu5SH</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2007,2008,2009,2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>980000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Strategic Award</gtr:description><gtr:end>2020-04-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef> The Wellcome Trust (equipment and the Synaptopathies strategic award (104033/z/14/z)</gtr:fundingRef><gtr:id>75385B5E-59FA-4DA9-BE74-2FF5633746CC</gtr:id><gtr:outcomeId>56dda8c7bbcb17.45050507</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Proof of concept trial</gtr:description><gtr:end>2016-07-02</gtr:end><gtr:fundingOrg>Higher Education Funding Council for England (HEFCE)</gtr:fundingOrg><gtr:id>720861B6-8E89-4439-9D02-435053E521CA</gtr:id><gtr:outcomeId>58a458898422b7.13275418</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2016-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1543444</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Project grant: A randomised controlled trial of efficacy of heat shock protein upregulation in IBM</gtr:description><gtr:fundingOrg>Food and Drug Administration (FDA)</gtr:fundingOrg><gtr:id>CEB9ABF6-30B3-444B-93C4-1F9422D9F68C</gtr:id><gtr:outcomeId>58a457b293f2b9.22814157</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>661363</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Equipment award Wellcome Trust</gtr:description><gtr:end>2016-07-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>6FD92792-9408-4CD8-A8AB-4A1B536F50F8</gtr:id><gtr:outcomeId>fUgJjWPHDak</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-08-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Improved and larger range of neurogenetic tests</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>2EC87011-6981-4577-9D05-485F3121852D</gtr:id><gtr:impact>Improved and larger range of neurogenetic tests. This leads to greater research and a better service for patients</gtr:impact><gtr:outcomeId>19BADAC486D</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>Synaptopathies collaboration</gtr:description><gtr:id>ED17D5BD-C60C-4477-B693-9D86389075D9</gtr:id><gtr:impact>Synaptopathies collaboration</gtr:impact><gtr:outcomeId>56ddb2d8515fe7.79983577</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Synaptopathies collaboration</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Synaptopathies collaboration</gtr:description><gtr:id>1D05C94A-9F88-4811-B5E2-202644A3AE57</gtr:id><gtr:impact>Synaptopathies collaboration</gtr:impact><gtr:outcomeId>56ddb28f1d6eb5.21354160</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Synaptopathies collaboration</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Muscle international registry and biobank</gtr:description><gtr:id>7AE74750-9320-4999-9A40-B65D68DE307C</gtr:id><gtr:impact>Muscle international registry and biobank</gtr:impact><gtr:outcomeId>edKKnP7UcCJ</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Muscle international registry and biobank</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Genome sequencing and GeCIP</gtr:description><gtr:id>8F683722-C827-4DA4-A7AD-A47D4DAEE370</gtr:id><gtr:impact>Genome sequencing and GeCIP</gtr:impact><gtr:outcomeId>56ddb25982b527.74911307</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Genome sequencing and GeCIP</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:url>http://www.genomicsengland.co.uk</gtr:url><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>B13AB43B-2A46-4D7F-BEC3-FE28C06EDD49</gtr:id><gtr:title>Neuropathological features of genetically confirmed DYT1 dystonia: investigating disease-specific inclusions.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b2ac56d4a5087705921cb2ad66bb2a3"><gtr:id>9b2ac56d4a5087705921cb2ad66bb2a3</gtr:id><gtr:otherNames>Paudel R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2051-5960</gtr:issn><gtr:outcomeId>56a4096eb85313.64697040</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>20A365CE-30C3-44C1-8F00-C66FB5018E3F</gtr:id><gtr:title>Clinical and genetic characterization of leukoencephalopathies in adults.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6867986db8e51578e846cfba3cd72c66"><gtr:id>6867986db8e51578e846cfba3cd72c66</gtr:id><gtr:otherNames>Lynch DS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>5aa93eea3185d2.01438087</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D8376F13-62AA-4F96-A01A-DBEA2108FE5F</gtr:id><gtr:title>Verification of Inter-laboratorial Genotyping Consistency in the Molecular Diagnosis of Polyglutamine Spinocerebellar Ataxias.</gtr:title><gtr:parentPublicationTitle>Journal of molecular neuroscience : MN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f7ca917b7a90a50ab88287e6b9367286"><gtr:id>f7ca917b7a90a50ab88287e6b9367286</gtr:id><gtr:otherNames>Ramos A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0895-8696</gtr:issn><gtr:outcomeId>56a40968a53572.88065710</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ECBF57D0-DA9B-4379-9196-02C19A211492</gtr:id><gtr:title>Kohlsch&amp;uuml;tter-T&amp;ouml;nz syndrome: mutations in ROGDI and evidence of genetic heterogeneity.</gtr:title><gtr:parentPublicationTitle>Human mutation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2e8088f2d6e90105cd78b127c6516c9f"><gtr:id>2e8088f2d6e90105cd78b127c6516c9f</gtr:id><gtr:otherNames>Tucci A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1059-7794</gtr:issn><gtr:outcomeId>pm_15519_29_23086778</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9CF0D47C-457C-4CFF-B56A-0FB952EB6FAD</gtr:id><gtr:title>Absence of HINT1 mutations in a UK and Spanish cohort of patients with inherited neuropathies.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70045987ef050d49a7a1c26b398ecd06"><gtr:id>70045987ef050d49a7a1c26b398ecd06</gtr:id><gtr:otherNames>Horga A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>56a4096997a557.19231071</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B7F7536E-89DE-4408-AD2F-670EE7898205</gtr:id><gtr:title>Autosomal-recessive cerebellar ataxia caused by a novel ADCK3 mutation that elongates the protein: clinical, genetic and biochemical characterisation.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/75880868018d92d0b7d54e2c82d1b2bc"><gtr:id>75880868018d92d0b7d54e2c82d1b2bc</gtr:id><gtr:otherNames>Liu YT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>5462974073c8c0.14968936</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>12DE3231-214F-4A8B-A86B-D1E689AF3912</gtr:id><gtr:title>Mutant COQ2 in multiple-system atrophy.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ff2cda0ff39441e9d379b03cb269851"><gtr:id>3ff2cda0ff39441e9d379b03cb269851</gtr:id><gtr:otherNames>Schottlaender LV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>54629742cf5770.72842901</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B4CDC3FF-1846-4982-BECB-49BD371CA2EF</gtr:id><gtr:title>De novo KCNA2 mutations cause hereditary spastic paraplegia.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c9ffda67425e994f02c670de63593986"><gtr:id>c9ffda67425e994f02c670de63593986</gtr:id><gtr:otherNames>Manole A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>58c7eec2cc5450.84221112</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A2455167-76D0-4DD5-83A8-CFC168144E97</gtr:id><gtr:title>Clinical implications of genetic advances in Charcot-Marie-Tooth disease.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e200f814262dac4d6b88ac30584c047"><gtr:id>8e200f814262dac4d6b88ac30584c047</gtr:id><gtr:otherNames>Rossor AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1759-4758</gtr:issn><gtr:outcomeId>pm_15519_29_24018473</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BABCCFA2-32C5-4A87-91A2-11A34934928F</gtr:id><gtr:title>Concomitant progressive supranuclear palsy and chronic traumatic encephalopathy in a boxer.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/79c943d719ca6749410f754081f54667"><gtr:id>79c943d719ca6749410f754081f54667</gtr:id><gtr:otherNames>Ling H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2051-5960</gtr:issn><gtr:outcomeId>54629741bd8da2.69740288</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A40318D9-1AA6-49A0-9833-DE2505014980</gtr:id><gtr:title>Faulty cardiac repolarization reserve in alternating hemiplegia of childhood broadens the phenotype.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/159c8c7cefbd596fac1d4f5555aa91ee"><gtr:id>159c8c7cefbd596fac1d4f5555aa91ee</gtr:id><gtr:otherNames>Jaffer F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>56a40967eb2611.14469790</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EE0C16C9-E88A-497E-8F7D-8D36731FE9D4</gtr:id><gtr:title>Pure Cerebellar Ataxia with Homozygous Mutations in the PNPLA6 Gene.</gtr:title><gtr:parentPublicationTitle>Cerebellum (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f412cc6b7d29c6e9685797bea1d962d2"><gtr:id>f412cc6b7d29c6e9685797bea1d962d2</gtr:id><gtr:otherNames>Wiethoff S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1473-4222</gtr:issn><gtr:outcomeId>58c7eec3353206.91987181</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D1A2ABC4-5A8B-4908-B3D6-595613BA71FD</gtr:id><gtr:title>Benefit of carbamazepine in a patient with hemiplegic migraine associated with PRRT2 mutation.</gtr:title><gtr:parentPublicationTitle>Developmental medicine and child neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/191a34cadb34bb04b665c6b4cd8bed4b"><gtr:id>191a34cadb34bb04b665c6b4cd8bed4b</gtr:id><gtr:otherNames>Dale RC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0012-1622</gtr:issn><gtr:outcomeId>5462974176f2d6.36262943</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>906FC3C5-705C-4B62-BBF2-FE3685DDE2DE</gtr:id><gtr:title>Investigation of next-generation sequencing technologies as a diagnostic tool for amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa2841aab396cd2b4f18a94e7a29ae23"><gtr:id>aa2841aab396cd2b4f18a94e7a29ae23</gtr:id><gtr:otherNames>Morgan S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>56a4096d352552.37092377</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A785FAE4-5226-4F5F-BC18-4C83AB7B67A5</gtr:id><gtr:title>De Novo Mutations in PDE10A Cause Childhood-Onset Chorea with Bilateral Striatal Lesions.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ed0f28b35d5e4240d5af6d917b092bf"><gtr:id>8ed0f28b35d5e4240d5af6d917b092bf</gtr:id><gtr:otherNames>Mencacci NE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>58c7eeca21b045.36026166</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A7A65209-C833-4303-B3E3-45D0038C57C7</gtr:id><gtr:title>Recent advances in bulbar syndromes: genetic causes and disease mechanisms.</gtr:title><gtr:parentPublicationTitle>Current opinion in neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c9ffda67425e994f02c670de63593986"><gtr:id>c9ffda67425e994f02c670de63593986</gtr:id><gtr:otherNames>Manole A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1350-7540</gtr:issn><gtr:outcomeId>546297439f3932.11263958</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3EE41680-0B1A-4EB4-B6DE-AA5DD8F55A67</gtr:id><gtr:title>VPS13C-Another Hint at Mitochondrial Dysfunction in Familial Parkinson's Disease.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f2de2cd48d9052ac53c03db9958be261"><gtr:id>f2de2cd48d9052ac53c03db9958be261</gtr:id><gtr:otherNames>Schreglmann SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>58c7eec4daa478.57365655</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C495BFE7-FA11-42E2-B908-00F55D4805CD</gtr:id><gtr:title>Pathological ribonuclease H1 causes R-loop depletion and aberrant DNA segregation in mitochondria.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d0868462ff4eec27e8eea7f7c7c64375"><gtr:id>d0868462ff4eec27e8eea7f7c7c64375</gtr:id><gtr:otherNames>Akman G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>58c7eec89425b1.30939142</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D59AECFA-180E-4F60-8AA3-30765D252746</gtr:id><gtr:title>Exome sequencing uncovers hidden pathways in familial and sporadic ALS.</gtr:title><gtr:parentPublicationTitle>Nature neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9960cd808582e52821f0e586e2ba9176"><gtr:id>9960cd808582e52821f0e586e2ba9176</gtr:id><gtr:otherNames>Bettencourt C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1097-6256</gtr:issn><gtr:outcomeId>56a4096ca51bc1.18740967</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>70A78F74-D3FA-4007-B818-5933C22AB73F</gtr:id><gtr:title>DNA repair pathways underlie a common genetic mechanism modulating onset in polyglutamine diseases.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9960cd808582e52821f0e586e2ba9176"><gtr:id>9960cd808582e52821f0e586e2ba9176</gtr:id><gtr:otherNames>Bettencourt C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>58c7eec983ff40.65236389</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A353B70-325F-412C-BD46-5865EDBD7564</gtr:id><gtr:title>Severe axonal neuropathy is a late manifestation of SPG11.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c9ffda67425e994f02c670de63593986"><gtr:id>c9ffda67425e994f02c670de63593986</gtr:id><gtr:otherNames>Manole A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>58c7eec4819a78.36531428</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E5370124-2BBC-4E22-B8D3-B087ACC3AA57</gtr:id><gtr:title>Screening a UK amyotrophic lateral sclerosis cohort provides evidence of multiple origins of the C9orf72 expansion.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8d1a7eafc9d349e2e6367fcc16d31c49"><gtr:id>8d1a7eafc9d349e2e6367fcc16d31c49</gtr:id><gtr:otherNames>Fratta P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>54629743c60ff1.26431156</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B39346EE-76E0-4BE3-9DAB-0CD8FE497583</gtr:id><gtr:title>Syndromic associations and RNF216 mutations.</gtr:title><gtr:parentPublicationTitle>Parkinsonism &amp; related disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b7ff253acba98dc4017e32a051ce3e9"><gtr:id>6b7ff253acba98dc4017e32a051ce3e9</gtr:id><gtr:otherNames>Ganos C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1353-8020</gtr:issn><gtr:outcomeId>56a40966e735d9.20805480</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E451D8D2-C5C7-42A5-A30B-29AC2E074CE8</gtr:id><gtr:title>Next-generation sequencing in neuromuscular diseases.</gtr:title><gtr:parentPublicationTitle>Current opinion in neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/af3d01a303955ec87d9796b29ee01eb6"><gtr:id>af3d01a303955ec87d9796b29ee01eb6</gtr:id><gtr:otherNames>Efthymiou S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1350-7540</gtr:issn><gtr:outcomeId>58c7eec7f02423.19690192</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8E99B586-9726-4287-9D15-5E775FECCBEF</gtr:id><gtr:title>SIGMAR1 mutation associated with autosomal recessive Silver-like syndrome.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70045987ef050d49a7a1c26b398ecd06"><gtr:id>70045987ef050d49a7a1c26b398ecd06</gtr:id><gtr:otherNames>Horga A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>58c7eec78ed4f9.39489998</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1CDF7F51-51F8-44BE-9283-DFF6AB494952</gtr:id><gtr:title>Mutations in SLC39A14 disrupt manganese homeostasis and cause childhood-onset parkinsonism-dystonia.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fa078abc03e0426b87406530fac025ca"><gtr:id>fa078abc03e0426b87406530fac025ca</gtr:id><gtr:otherNames>Tuschl K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>58c7eec57a22a8.75008271</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E31B6254-244C-4F44-A6CA-051745D16802</gtr:id><gtr:title>Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf8b293c57e2abbe75629b0924e21ef0"><gtr:id>cf8b293c57e2abbe75629b0924e21ef0</gtr:id><gtr:otherNames>Nalls MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>54629743784bd7.47978520</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0F4DD5EB-D69C-4A90-AC24-73321547FD1F</gtr:id><gtr:title>Gene co-expression networks shed light into diseases of brain iron accumulation.</gtr:title><gtr:parentPublicationTitle>Neurobiology of disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9960cd808582e52821f0e586e2ba9176"><gtr:id>9960cd808582e52821f0e586e2ba9176</gtr:id><gtr:otherNames>Bettencourt C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0969-9961</gtr:issn><gtr:outcomeId>56a409667a5ab9.40053577</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>01503282-AF30-4766-B8C2-CF823C3D49EF</gtr:id><gtr:title>MFN2 deletion of exons 7 and 8: founder mutation in the UK population.</gtr:title><gtr:parentPublicationTitle>Journal of the peripheral nervous system : JPNS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/230c6ae6cfa4b1a456b4b475e336d4da"><gtr:id>230c6ae6cfa4b1a456b4b475e336d4da</gtr:id><gtr:otherNames>Carr AS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1085-9489</gtr:issn><gtr:outcomeId>56a4096b7b6925.90339107</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A3ACF93-F02E-4BE6-9DDC-E325253A0E15</gtr:id><gtr:title>DYT6 Dystonia: A Neuropathological Study.</gtr:title><gtr:parentPublicationTitle>Neuro-degenerative diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b2ac56d4a5087705921cb2ad66bb2a3"><gtr:id>9b2ac56d4a5087705921cb2ad66bb2a3</gtr:id><gtr:otherNames>Paudel R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1660-2854</gtr:issn><gtr:outcomeId>56a40967256368.30094204</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D41EBD7-A24E-4BA2-9317-1B978DB600C8</gtr:id><gtr:title>Genetic analysis of inherited leukodystrophies: genotype-phenotype correlations in the CSF1R gene.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/56b2d14505f1916bc463c5643c1c28d8"><gtr:id>56b2d14505f1916bc463c5643c1c28d8</gtr:id><gtr:otherNames>Guerreiro R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn><gtr:outcomeId>pm_15519_29_23649896</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BF592663-9DB6-4F16-98BD-23ADBD7DD68E</gtr:id><gtr:title>Developmental regulation of tau splicing is disrupted in stem cell-derived neurons from frontotemporal dementia patients with the 10 + 16 splice-site mutation in MAPT.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b39d653d4d3c3376c5d341f10c040edc"><gtr:id>b39d653d4d3c3376c5d341f10c040edc</gtr:id><gtr:otherNames>Sposito T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>56a40969555394.11783685</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>951694CF-9ACD-43FD-B67A-84E8EF0153B1</gtr:id><gtr:title>Redefining the phenotype of ALSP andmutation-related leukodystrophy.</gtr:title><gtr:parentPublicationTitle>Neurology. Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72581e71106155fae7679c5a668017b5"><gtr:id>72581e71106155fae7679c5a668017b5</gtr:id><gtr:otherNames>Lakshmanan R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2376-7839</gtr:issn><gtr:outcomeId>58c7eec299cae4.20362245</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4489BAA4-E3B0-453A-A6FB-7C0FB9648C2A</gtr:id><gtr:title>Homozygous mutations in VAMP1 cause a presynaptic congenital myasthenic syndrome.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c12954aa30a8fba72f3439d776bda00b"><gtr:id>c12954aa30a8fba72f3439d776bda00b</gtr:id><gtr:otherNames>Salpietro V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>58c7eec25ec5b2.59299037</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5854EE8F-1A5B-440A-A332-8AE8FBBDACF5</gtr:id><gtr:title>Mutational analysis of PMP22, EGR2, LITAF and NEFL in Greek Charcot-Marie-Tooth type 1 patients.</gtr:title><gtr:parentPublicationTitle>Clinical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a0141d4dc212d3dc1de00d97ceee75f7"><gtr:id>a0141d4dc212d3dc1de00d97ceee75f7</gtr:id><gtr:otherNames>Koutsis G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0009-9163</gtr:issn><gtr:outcomeId>pm_15519_29_22765307</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7F990E8C-BC27-422D-A4FA-9BBE4F586F78</gtr:id><gtr:title>SBF1 mutations associated with autosomal recessive axonal neuropathy with cranial nerve involvement.</gtr:title><gtr:parentPublicationTitle>Neurogenetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c9ffda67425e994f02c670de63593986"><gtr:id>c9ffda67425e994f02c670de63593986</gtr:id><gtr:otherNames>Manole A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1364-6745</gtr:issn><gtr:outcomeId>58c7eec3ea7c92.48760396</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FC95D8A1-5BA0-4224-B8D3-7598856536A7</gtr:id><gtr:title>A 6.4 Mb duplication of the a-synuclein locus causing frontotemporal dementia and Parkinsonism: phenotype-genotype correlations.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/697536feebefd233256c0907479ff552"><gtr:id>697536feebefd233256c0907479ff552</gtr:id><gtr:otherNames>Kara E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn><gtr:outcomeId>5462974332c0d5.57292373</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6D318FA5-73D2-4528-92CF-C3C67789FEE7</gtr:id><gtr:title>Charcot-Marie-Tooth disease type 2C and scapuloperoneal muscular atrophy overlap syndrome in a patient with the R232C TRPV4 mutation.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a0141d4dc212d3dc1de00d97ceee75f7"><gtr:id>a0141d4dc212d3dc1de00d97ceee75f7</gtr:id><gtr:otherNames>Koutsis G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>56a4096a280c82.49246620</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F10CCE0B-3634-4CF5-8157-4A8A6F08BCB6</gtr:id><gtr:title>DNA isolation protocol effects on nuclear DNA analysis by microarrays, droplet digital PCR, and whole genome sequencing, and on mitochondrial DNA copy number estimation.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/76c2f965aac424ae82975cc69a19e1f8"><gtr:id>76c2f965aac424ae82975cc69a19e1f8</gtr:id><gtr:otherNames>Nacheva E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5aa93ee8d92817.72281319</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>38D9265B-653A-427D-BAEF-DC7E3CC558ED</gtr:id><gtr:title>Analysis of Mutations in AARS2 in a Series of CSF1R-Negative Patients With Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6867986db8e51578e846cfba3cd72c66"><gtr:id>6867986db8e51578e846cfba3cd72c66</gtr:id><gtr:otherNames>Lynch DS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn><gtr:outcomeId>58c7eec71d4765.83547065</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CC11CFBB-6A0C-4EB6-8584-0DD6991D4060</gtr:id><gtr:title>Assessment of Parkinson's disease risk loci in Greece.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/697536feebefd233256c0907479ff552"><gtr:id>697536feebefd233256c0907479ff552</gtr:id><gtr:otherNames>Kara E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>pm_15519_29_24080174</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3323FB5B-BB1F-4E46-A9D9-7F2E269FBDB4</gtr:id><gtr:title>DNA repair in the trinucleotide repeat disorders.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/59ac40b969c64db850e438e12bb3e323"><gtr:id>59ac40b969c64db850e438e12bb3e323</gtr:id><gtr:otherNames>Jones L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>58c7eec6304fc1.35669103</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8FFE3C02-7DB6-4E96-9648-3E7D42007D16</gtr:id><gtr:title>Brain iron accumulation affects myelin-related molecular systems implicated in a rare neurogenetic disease family with neuropsychiatric features.</gtr:title><gtr:parentPublicationTitle>Molecular psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b7db88df9f44c9c37b5e7c23fe5b4135"><gtr:id>b7db88df9f44c9c37b5e7c23fe5b4135</gtr:id><gtr:otherNames>Heidari M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1359-4184</gtr:issn><gtr:outcomeId>56a409660ec789.93763757</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>997CFEF9-3C4D-47E8-8D9F-728B94F3CBC7</gtr:id><gtr:title>Tubular Aggregates and Cylindrical Spirals Have Distinct Immunohistochemical Signatures.</gtr:title><gtr:parentPublicationTitle>Journal of neuropathology and experimental neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8655b80f35da06543063892dc80fc48b"><gtr:id>8655b80f35da06543063892dc80fc48b</gtr:id><gtr:otherNames>Brady S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-3069</gtr:issn><gtr:outcomeId>58c7eec6e64d01.00619670</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9E3FB2E8-84BE-4332-8FE2-EFE90779B1C3</gtr:id><gtr:title>Rapidly progressive asymmetrical weakness in Charcot-Marie-Tooth disease type 4J resembles chronic inflammatory demyelinating polyneuropathy.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bcb877e01dd9f33040f7fc09646ce4b6"><gtr:id>bcb877e01dd9f33040f7fc09646ce4b6</gtr:id><gtr:otherNames>Cottenie E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>pm_15519_29_23489662</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8CE8FD5F-DC41-4875-9317-492F48B8FAC1</gtr:id><gtr:title>The frequency of spinocerebellar ataxia type 23 in a UK population.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/41c4d0dfc03600335329f8ac761e66b0"><gtr:id>41c4d0dfc03600335329f8ac761e66b0</gtr:id><gtr:otherNames>Fawcett K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>pm_15519_29_23108490</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1E0FBE70-D50C-4FE3-9A7E-EA5FB7309C38</gtr:id><gtr:title>Mutations in the autoregulatory domain of ?-tubulin 4a cause hereditary dystonia.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/13a59fbd288093fca2ace1bf37b42241"><gtr:id>13a59fbd288093fca2ace1bf37b42241</gtr:id><gtr:otherNames>Hersheson J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>pm_15519_29_23424103</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8952ACB5-C22A-4595-B68C-086ACEB5EAD6</gtr:id><gtr:title>Dopaminergic neuronal imaging in genetic Parkinson's disease: insights into pathogenesis.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fb527c8f47b11cfd2bb90849f52723e8"><gtr:id>fb527c8f47b11cfd2bb90849f52723e8</gtr:id><gtr:otherNames>McNeill A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_15519_29_23935950</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C0CBD8F7-F786-4BE6-BC6D-A149F4D6D579</gtr:id><gtr:title>Homozygous mutation incausing distal vacuolar myopathy and motor neuropathy.</gtr:title><gtr:parentPublicationTitle>Neurology. Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1d1503307a90897a52487453a039bddd"><gtr:id>1d1503307a90897a52487453a039bddd</gtr:id><gtr:otherNames>Bugiardini E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2376-7839</gtr:issn><gtr:outcomeId>5aa93ee895cc87.61684757</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F53F3863-4A56-48AB-84EF-B2E4F3084258</gtr:id><gtr:title>Multiple system atrophy: the application of genetics in understanding etiology.</gtr:title><gtr:parentPublicationTitle>Clinical autonomic research : official journal of the Clinical Autonomic Research Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5bb0da6bb7eb8d81a012bd35afacacdc"><gtr:id>5bb0da6bb7eb8d81a012bd35afacacdc</gtr:id><gtr:otherNames>Federoff M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0959-9851</gtr:issn><gtr:outcomeId>56a4096de2d5a4.27156370</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4D5E0B98-1DEF-4368-B7A7-0777633F2911</gtr:id><gtr:title>Ongoing developments in sporadic inclusion body myositis.</gtr:title><gtr:parentPublicationTitle>Current rheumatology reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/973fa2ad4c5615dcdcf432bf2cfb16da"><gtr:id>973fa2ad4c5615dcdcf432bf2cfb16da</gtr:id><gtr:otherNames>Machado PM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1523-3774</gtr:issn><gtr:outcomeId>56a4096e869015.28963566</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D674CE88-30CB-4132-9185-A62271C3D577</gtr:id><gtr:title>Multiple system atrophy is not caused by C9orf72 hexanucleotide repeat expansions.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0a34ae6889d51d0636773dd2548e288e"><gtr:id>0a34ae6889d51d0636773dd2548e288e</gtr:id><gtr:otherNames>Scholz SW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>546297442a8b88.32062614</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DC464F42-6729-4C25-B143-2EC9BC86B645</gtr:id><gtr:title>A novel a-synuclein missense mutation in Parkinson disease.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad6d814d95a541c7e3a165cbafd92058"><gtr:id>ad6d814d95a541c7e3a165cbafd92058</gtr:id><gtr:otherNames>Proukakis C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>pm_15519_29_23427326</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A1F15679-79CA-40FE-B250-0DBC896F3802</gtr:id><gtr:title>The Clinical Relevance of Microbleeds in Stroke study (CROMIS-2): rationale, design, and methods.</gtr:title><gtr:parentPublicationTitle>International journal of stroke : official journal of the International Stroke Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d6981c962662ff970fe9940bc30407e3"><gtr:id>d6981c962662ff970fe9940bc30407e3</gtr:id><gtr:otherNames>Charidimou A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1747-4930</gtr:issn><gtr:outcomeId>56a409684387d9.55215597</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E27DF766-7265-4975-B7D2-B366B94E06F7</gtr:id><gtr:title>Truncating and missense mutations in IGHMBP2 cause Charcot-Marie Tooth disease type 2.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bcb877e01dd9f33040f7fc09646ce4b6"><gtr:id>bcb877e01dd9f33040f7fc09646ce4b6</gtr:id><gtr:otherNames>Cottenie E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>56a4096f2b9fa4.77241995</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8BA33268-6852-4C6F-8E0D-0EBCE0CC0A15</gtr:id><gtr:title>Mutations in SNX14 cause a distinctive autosomal-recessive cerebellar ataxia and intellectual disability syndrome.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a7dda45248e47eb0023a4ccbd6908c4e"><gtr:id>a7dda45248e47eb0023a4ccbd6908c4e</gtr:id><gtr:otherNames>Thomas AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>56a4096eec8457.78218357</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8B710FF8-EAAF-4255-A843-8466C6287E94</gtr:id><gtr:title>The glucocerobrosidase E326K variant predisposes to Parkinson's disease, but does not cause Gaucher's disease.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f95aa813f473ac4f55c06f44414f70d4"><gtr:id>f95aa813f473ac4f55c06f44414f70d4</gtr:id><gtr:otherNames>Duran R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>pm_15519_29_23225227</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E325C203-8AB3-4373-9CB9-FABD042F3C3D</gtr:id><gtr:title>Rhabdomyolysis: a genetic perspective.</gtr:title><gtr:parentPublicationTitle>Orphanet journal of rare diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb7de9e0bdbda47bf81b86f2720f04e3"><gtr:id>bb7de9e0bdbda47bf81b86f2720f04e3</gtr:id><gtr:otherNames>Scalco RS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1750-1172</gtr:issn><gtr:outcomeId>56a4096c438747.55783436</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DAA262C5-0F1B-4733-883E-B0955F8A1C70</gtr:id><gtr:title>Mutations in BICD2 cause dominant congenital spinal muscular atrophy and hereditary spastic paraplegia.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1707385a316c35c6294898aff4bc0ae7"><gtr:id>1707385a316c35c6294898aff4bc0ae7</gtr:id><gtr:otherNames>Oates EC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>pm_15519_29_23664120</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD276A1A-CDBC-4FE3-AAE9-AA44846BC831</gtr:id><gtr:title>Novel mutations mapping to the fourth sodium channel domain of Nav1.7 result in variable clinical manifestations of primary erythromelalgia.</gtr:title><gtr:parentPublicationTitle>Neuromolecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7276d1e256346a632b0a5edf660a0b74"><gtr:id>7276d1e256346a632b0a5edf660a0b74</gtr:id><gtr:otherNames>Cregg R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1535-1084</gtr:issn><gtr:outcomeId>pm_15519_29_23292638</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A203159E-E031-44FC-B60B-287D0F831EBF</gtr:id><gtr:title>Sporadic inclusion body myositis: the genetic contributions to the pathogenesis.</gtr:title><gtr:parentPublicationTitle>Orphanet journal of rare diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5740d7dfacf41317fd1190662cfe9c79"><gtr:id>5740d7dfacf41317fd1190662cfe9c79</gtr:id><gtr:otherNames>Gang Q</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1750-1172</gtr:issn><gtr:outcomeId>pm_540e192e192422e1e</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1F1EF8B9-96BC-42DA-94E1-14BD812A2F6D</gtr:id><gtr:title>Large C9orf72 hexanucleotide repeat expansions are seen in multiple neurodegenerative syndromes and are more frequent than expected in the UK population.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72f7fb44cb0e9d3dbae03fa9e859951a"><gtr:id>72f7fb44cb0e9d3dbae03fa9e859951a</gtr:id><gtr:otherNames>Beck J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>pm_15519_29_23434116</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>095CAA42-F2AC-4EE2-A4E9-B624593D9ADD</gtr:id><gtr:title>Cerebral small vessel disease-related protease HtrA1 processes latent TGF-? binding protein 1 and facilitates TGF-? signaling.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/128b97c9a0949e6460aade7db5f751eb"><gtr:id>128b97c9a0949e6460aade7db5f751eb</gtr:id><gtr:otherNames>Beaufort N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>54629744bb0a73.11225902</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B2D76A79-A57A-4E34-BA98-7AEA7546BD92</gtr:id><gtr:title>THAP1 mutations in a Greek primary blepharospasm series.</gtr:title><gtr:parentPublicationTitle>Parkinsonism &amp; related disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7683c72a503be0311ba813667c505f75"><gtr:id>7683c72a503be0311ba813667c505f75</gtr:id><gtr:otherNames>Xiromerisiou G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1353-8020</gtr:issn><gtr:outcomeId>pm_15519_29_23036512</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C9FEC31D-3BAE-4746-A14E-08823354A7FD</gtr:id><gtr:title>Peripheral neuropathy predicts nuclear gene defect in patients with mitochondrial ophthalmoplegia.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70045987ef050d49a7a1c26b398ecd06"><gtr:id>70045987ef050d49a7a1c26b398ecd06</gtr:id><gtr:otherNames>Horga A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>54629744516a73.55359918</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D92A616B-9189-4F72-BA88-1E7541F3250D</gtr:id><gtr:title>?-Propeller protein-associated neurodegeneration: a new X-linked dominant disorder with brain iron accumulation.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/15207479c0ab3461d4182e7e05fa69ea"><gtr:id>15207479c0ab3461d4182e7e05fa69ea</gtr:id><gtr:otherNames>Hayflick SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_15519_29_23687123</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B866F577-6E98-4320-90B5-4813053B4A81</gtr:id><gtr:title>Forebrain deletion of the dystonia protein torsinA causes dystonic-like movements and loss of striatal cholinergic neurons.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d07df80fc290c1d52c3bc40ece361da1"><gtr:id>d07df80fc290c1d52c3bc40ece361da1</gtr:id><gtr:otherNames>Pappas SS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn><gtr:outcomeId>56a4096ba95413.70240517</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D91586C6-4BEE-4DC5-A58D-CF39E9DA64AE</gtr:id><gtr:title>Defective N-linked protein glycosylation pathway in congenital myasthenic syndromes.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3544c3d604dfbcaee394d9a12def7ab8"><gtr:id>3544c3d604dfbcaee394d9a12def7ab8</gtr:id><gtr:otherNames>Houlden H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_15519_29_23436500</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2E0C134C-1A01-49C4-A243-F37880D0FC50</gtr:id><gtr:title>Clinicopathologic and molecular spectrum of-related mitochondrial disease.</gtr:title><gtr:parentPublicationTitle>Neurology. Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1d1503307a90897a52487453a039bddd"><gtr:id>1d1503307a90897a52487453a039bddd</gtr:id><gtr:otherNames>Bugiardini E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2376-7839</gtr:issn><gtr:outcomeId>5aa93ee9cf0145.41510653</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>56FA81D0-AAE1-46CA-BBC7-7892D41F09F6</gtr:id><gtr:title>A novel HTRA1 exon 2 mutation causes loss of protease activity in a Pakistani CARASIL patient.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f3448b53cd01a1b60a66c2f94ca21c3"><gtr:id>9f3448b53cd01a1b60a66c2f94ca21c3</gtr:id><gtr:otherNames>Khaleeli Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>56a4096bdee9e2.31970876</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6ACBB508-3AAF-403A-8433-A97E1F866B4B</gtr:id><gtr:title>Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutation.</gtr:title><gtr:parentPublicationTitle>Molecular neurodegeneration</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8cf5553107e55c233b68c1efaf1db243"><gtr:id>8cf5553107e55c233b68c1efaf1db243</gtr:id><gtr:otherNames>Kiely AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1750-1326</gtr:issn><gtr:outcomeId>56a4096a8a4488.71657139</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>52FE4CDC-D12C-440A-8DCB-E71CAEA83F0D</gtr:id><gtr:title>Erratum to: Charcot-Marie-Tooth disease type 2C and scapuloperoneal muscular atrophy overlap syndrome in a patient with the R232C TRPV4 mutation.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a0141d4dc212d3dc1de00d97ceee75f7"><gtr:id>a0141d4dc212d3dc1de00d97ceee75f7</gtr:id><gtr:otherNames>Koutsis G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>56a40969bf4392.93812018</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E087A8E8-0883-484D-971E-69708A63409E</gtr:id><gtr:title>Hereditary spastic paraplegia in Greece: characterisation of a previously unexplored population using next-generation sequencing.</gtr:title><gtr:parentPublicationTitle>European journal of human genetics : EJHG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6867986db8e51578e846cfba3cd72c66"><gtr:id>6867986db8e51578e846cfba3cd72c66</gtr:id><gtr:otherNames>Lynch DS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1018-4813</gtr:issn><gtr:outcomeId>56a40968d83f88.32726274</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>19B60797-D23E-4B4F-A791-E3564E63CA37</gtr:id><gtr:title>The phenotypic spectrum of DYT24 due to ANO3 mutations.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d3b37a1ea4c6bb2dd69d484101a8d28c"><gtr:id>d3b37a1ea4c6bb2dd69d484101a8d28c</gtr:id><gtr:otherNames>Stamelou M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>54629741509c27.07505633</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>53FEA7E7-33DB-488E-A5F9-1BAA67176024</gtr:id><gtr:title>Parkinson's disease in GTP cyclohydrolase 1 mutation carriers.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ed0f28b35d5e4240d5af6d917b092bf"><gtr:id>8ed0f28b35d5e4240d5af6d917b092bf</gtr:id><gtr:otherNames>Mencacci NE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>5462974302d6a4.17325265</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CA72D31D-D875-4843-BCB8-7AF7589008A5</gtr:id><gtr:title>CAV3 mutations causing exercise intolerance, myalgia and rhabdomyolysis: Expanding the phenotypic spectrum of caveolinopathies.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb7de9e0bdbda47bf81b86f2720f04e3"><gtr:id>bb7de9e0bdbda47bf81b86f2720f04e3</gtr:id><gtr:otherNames>Scalco RS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>58c7eec8527fc2.35446189</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4C7EE456-B9F9-4F29-856B-A527442D2FFB</gtr:id><gtr:title>Cryptic Amyloidogenic Elements in the 3' UTRs of Neurofilament Genes Trigger Axonal Neuropathy.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/86c42c663e0f22036e78de1c30a1c181"><gtr:id>86c42c663e0f22036e78de1c30a1c181</gtr:id><gtr:otherNames>Rebelo AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>58c7eec5b50ae0.52037791</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>98994F6D-CF82-4991-9EE7-B62930970BCC</gtr:id><gtr:title>ADCY5 mutations are another cause of benign hereditary chorea.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ed0f28b35d5e4240d5af6d917b092bf"><gtr:id>8ed0f28b35d5e4240d5af6d917b092bf</gtr:id><gtr:otherNames>Mencacci NE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>56a4096ab9d4d9.60646755</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6C490048-AA02-4E90-9B2A-8E0E02AFDFEF</gtr:id><gtr:title>Exome sequence reveals mutations in CoA synthase as a cause of neurodegeneration with brain iron accumulation.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0c476215aba277f7032e95532684d5dc"><gtr:id>0c476215aba277f7032e95532684d5dc</gtr:id><gtr:otherNames>Dusi S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>54629740d49f65.52906933</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>949EF3C8-3E1E-43E0-8FE0-6A11C40ADEA2</gtr:id><gtr:title>Hypersomnia with dilated pupils in adenosine monophosphate deaminase (AMPD) deficiency.</gtr:title><gtr:parentPublicationTitle>Journal of sleep research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/454302726a4f2ef471ebd89121efa41c"><gtr:id>454302726a4f2ef471ebd89121efa41c</gtr:id><gtr:otherNames>Perumal MB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0962-1105</gtr:issn><gtr:outcomeId>pm_15519_29_24033727</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>35695B54-E4F5-4DC8-99CD-F4DA02035C00</gtr:id><gtr:title>The instability of the BTB-KELCH protein Gigaxonin causes Giant Axonal Neuropathy and constitutes a new penetrant and specific diagnostic test.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5da89de5ddb6f0c22aacb38b0bac15db"><gtr:id>5da89de5ddb6f0c22aacb38b0bac15db</gtr:id><gtr:otherNames>Boizot A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2051-5960</gtr:issn><gtr:outcomeId>5462974260e7f6.86064051</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>54ED8F58-0F6D-4E16-8D94-26CCE7EAE2FD</gtr:id><gtr:title>Analysis of Parkinson's disease brain-derived DNA for alpha-synuclein coding somatic mutations.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad6d814d95a541c7e3a165cbafd92058"><gtr:id>ad6d814d95a541c7e3a165cbafd92058</gtr:id><gtr:otherNames>Proukakis C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>546297423a3570.64051165</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>48B53EA6-0AE7-441B-AB29-FCB408E5BA47</gtr:id><gtr:title>Analysis of the prion protein gene in multiple system atrophy.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/034f6f958aa47e49cbb180fb10e1d728"><gtr:id>034f6f958aa47e49cbb180fb10e1d728</gtr:id><gtr:otherNames>Chelban V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>58c7eec697bc97.94691774</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>514851AA-CC91-4240-89C9-3C104EC5DFF8</gtr:id><gtr:title>The Parkinson's disease-linked proteins Fbxo7 and Parkin interact to mediate mitophagy.</gtr:title><gtr:parentPublicationTitle>Nature neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e905395803df499a5bf946eb9e5153e0"><gtr:id>e905395803df499a5bf946eb9e5153e0</gtr:id><gtr:otherNames>Burchell VS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1097-6256</gtr:issn><gtr:outcomeId>pm_15519_29_23933751</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A8E9A82-2702-4F68-954D-CF21BD18367F</gtr:id><gtr:title>HLA-DRB*1501 associations with magnetic resonance imaging measures of grey matter pathology in multiple sclerosis.</gtr:title><gtr:parentPublicationTitle>Multiple sclerosis and related disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c05a2a09474056b5d5c18a55d9bd46c8"><gtr:id>c05a2a09474056b5d5c18a55d9bd46c8</gtr:id><gtr:otherNames>Yaldizli ?</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2211-0348</gtr:issn><gtr:outcomeId>58c7eec9e88021.71288858</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>56E10048-8E28-4C4C-96D0-C5EAF1C85A0F</gtr:id><gtr:title>Novel C12orf65 mutations in patients with axonal neuropathy and optic atrophy.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2e8088f2d6e90105cd78b127c6516c9f"><gtr:id>2e8088f2d6e90105cd78b127c6516c9f</gtr:id><gtr:otherNames>Tucci A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>pm_15519_29_24198383</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0B4B2095-76C7-4889-8CDC-75B6EA54ABE0</gtr:id><gtr:title>Genetic advances in sporadic inclusion body myositis.</gtr:title><gtr:parentPublicationTitle>Current opinion in rheumatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5740d7dfacf41317fd1190662cfe9c79"><gtr:id>5740d7dfacf41317fd1190662cfe9c79</gtr:id><gtr:otherNames>Gang Q</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1040-8711</gtr:issn><gtr:outcomeId>56a4096754e073.49998093</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>65B350CE-CC3D-470B-8485-42BAE119D157</gtr:id><gtr:title>Hereditary sensory and autonomic neuropathy type 1 (HSANI) caused by a novel mutation in SPTLC2.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6742175c859dc2842759f84e6dd6f0e6"><gtr:id>6742175c859dc2842759f84e6dd6f0e6</gtr:id><gtr:otherNames>Murphy SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>pm_15519_29_23658386</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5B6EC242-C42B-4372-9023-31F335F2AA69</gtr:id><gtr:title>LRRK2 exonic variants and risk of multiple system atrophy.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4d05ae276ba007db1461e7f91f861892"><gtr:id>4d05ae276ba007db1461e7f91f861892</gtr:id><gtr:otherNames>Heckman MG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>54629744de35b6.66792199</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8541B878-C34A-40D3-9706-4C38E5802ACC</gtr:id><gtr:title>Extended phenotypic spectrum of KIF5A mutations: From spastic paraplegia to axonal neuropathy.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/75880868018d92d0b7d54e2c82d1b2bc"><gtr:id>75880868018d92d0b7d54e2c82d1b2bc</gtr:id><gtr:otherNames>Liu YT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>5462974355cc11.45350617</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F1BABE07-68A7-4E76-A40E-91EC05EFACF5</gtr:id><gtr:title>Somatic alpha-synuclein mutations in Parkinson's disease: hypothesis and preliminary data.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad6d814d95a541c7e3a165cbafd92058"><gtr:id>ad6d814d95a541c7e3a165cbafd92058</gtr:id><gtr:otherNames>Proukakis C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>pm_15519_29_23674490</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A3E290F9-9A70-4BB6-A2E9-A31221ECFCC5</gtr:id><gtr:title>C19orf12 mutation leads to a pallido-pyramidal syndrome.</gtr:title><gtr:parentPublicationTitle>Gene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f031c0b2f78e03012bc542323de4d08"><gtr:id>1f031c0b2f78e03012bc542323de4d08</gtr:id><gtr:otherNames>Kruer MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0378-1119</gtr:issn><gtr:outcomeId>54629741038135.22563328</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0509162A-6E18-4F4D-9056-B1BBDA526BD8</gtr:id><gtr:title>Exome sequencing expands the mutational spectrum of SPG8 in a family with spasticity responsive to L-DOPA treatment.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9960cd808582e52821f0e586e2ba9176"><gtr:id>9960cd808582e52821f0e586e2ba9176</gtr:id><gtr:otherNames>Bettencourt C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>pm_15519_29_23881105</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4EB76FF0-A0BC-4448-8081-F66B77BC4930</gtr:id><gtr:title>TDP-43 pathology in a patient carrying G2019S LRRK2&amp;nbsp;mutation and a novel p.Q124E MAPT.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/79c943d719ca6749410f754081f54667"><gtr:id>79c943d719ca6749410f754081f54667</gtr:id><gtr:otherNames>Ling H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>pm_15519_29_23664753</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>604DED05-E4AA-4E30-B855-467B6B78AF37</gtr:id><gtr:title>Dystonic opisthotonus: a &amp;quot;red flag&amp;quot; for neurodegeneration with brain iron accumulation syndromes?</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d3b37a1ea4c6bb2dd69d484101a8d28c"><gtr:id>d3b37a1ea4c6bb2dd69d484101a8d28c</gtr:id><gtr:otherNames>Stamelou M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>pm_15519_29_23736975</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>54B539DE-BBCB-406F-B9B8-6F9704FA5808</gtr:id><gtr:title>Heterogeneity in clinical features and disease severity in ataxia-associated SYNE1 mutations.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f412cc6b7d29c6e9685797bea1d962d2"><gtr:id>f412cc6b7d29c6e9685797bea1d962d2</gtr:id><gtr:otherNames>Wiethoff S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>58c7eec516ddb9.24620014</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CDBA739D-72C4-443D-AD26-4B2AB8516F37</gtr:id><gtr:title>Review: Insights into molecular mechanisms of disease in neurodegeneration with brain iron accumulation: unifying theories.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/33fdd530dd8d5783625da53463d9f727"><gtr:id>33fdd530dd8d5783625da53463d9f727</gtr:id><gtr:otherNames>Arber CE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>56a4096d069932.30978528</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9AB4C465-B36C-450C-9362-9B1812E0603F</gtr:id><gtr:title>Pilot phenotype and natural history study of hereditary neuropathies caused by mutations in the HSPB1 gene.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e200f814262dac4d6b88ac30584c047"><gtr:id>8e200f814262dac4d6b88ac30584c047</gtr:id><gtr:otherNames>Rossor AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>58c7eec65a8784.63257873</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>85D76BA8-1956-4FBF-889E-FBABA72C43C3</gtr:id><gtr:title>a-Synuclein mutations cluster around a putative protein loop.</gtr:title><gtr:parentPublicationTitle>Neuroscience letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/697536feebefd233256c0907479ff552"><gtr:id>697536feebefd233256c0907479ff552</gtr:id><gtr:otherNames>Kara E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0304-3940</gtr:issn><gtr:outcomeId>pm_15519_29_23669636</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>98104109-D637-4137-83A3-BD60A214703D</gtr:id><gtr:title>Rare variants in SQSTM1 and VCP genes and risk of sporadic inclusion body myositis.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5740d7dfacf41317fd1190662cfe9c79"><gtr:id>5740d7dfacf41317fd1190662cfe9c79</gtr:id><gtr:otherNames>Gang Q</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>58c7eec75b4974.11468102</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EB389F81-4038-496F-989D-F5CB99022290</gtr:id><gtr:title>MSA-C or SCA 17? A clinicopathological case update.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f07a33be90f6f19bd438059328a9dbb8"><gtr:id>f07a33be90f6f19bd438059328a9dbb8</gtr:id><gtr:otherNames>Doherty KM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>58c7eec4a906b1.58904398</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1E0A3C28-4E68-4B5D-951A-3B638484DCB7</gtr:id><gtr:title>Novel HSAN1 mutation in serine palmitoyltransferase resides at a putative phosphorylation site that is involved in regulating substrate specificity.</gtr:title><gtr:parentPublicationTitle>Neuromolecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4de2a860f153838d0613290971dc2033"><gtr:id>4de2a860f153838d0613290971dc2033</gtr:id><gtr:otherNames>Ernst D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1535-1084</gtr:issn><gtr:outcomeId>56a4096d69b521.57465978</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>54958BAE-B7AE-492B-AF07-4B937C808E5A</gtr:id><gtr:title>Defects of RNA metabolism in the pathogenesis of spinal muscular atrophy.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bd4d0f80718b51ee04d0d4b40400c130"><gtr:id>bd4d0f80718b51ee04d0d4b40400c130</gtr:id><gtr:otherNames>Bertini E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>5462974213b6c9.14520346</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F1527842-38DF-424D-95B3-07A0ABFCF6B1</gtr:id><gtr:title>Alpha-synuclein mRNA expression in oligodendrocytes in MSA.</gtr:title><gtr:parentPublicationTitle>Glia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1a25a6988d5aadc65741d1b68af379f6"><gtr:id>1a25a6988d5aadc65741d1b68af379f6</gtr:id><gtr:otherNames>Asi YT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0894-1491</gtr:issn><gtr:outcomeId>54629741e1f2d4.25980501</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>75EEA072-578D-46FF-8225-1336B7D88061</gtr:id><gtr:title>Madras motor neuron disease (MMND) is distinct from the riboflavin transporter genetic defects that cause Brown-Vialetto-Van Laere syndrome.</gtr:title><gtr:parentPublicationTitle>Journal of the neurological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2a2993fc77ed42ab56e9055e6aaaf4cc"><gtr:id>2a2993fc77ed42ab56e9055e6aaaf4cc</gtr:id><gtr:otherNames>Nalini A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-510X</gtr:issn><gtr:outcomeId>pm_15519_29_24139842</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8A04619A-7ABD-45EF-98F9-308452B79A76</gtr:id><gtr:title>Genetic and clinical characteristics of-related Charcot-Marie-Tooth disease.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70045987ef050d49a7a1c26b398ecd06"><gtr:id>70045987ef050d49a7a1c26b398ecd06</gtr:id><gtr:otherNames>Horga A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>5aa93ee933f687.43989614</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C54C8A88-932E-4860-A26B-3BB3679CD477</gtr:id><gtr:title>Triple trouble: a striking new phenotype or competing genes in a family with hereditary spastic paraplegia.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/034f6f958aa47e49cbb180fb10e1d728"><gtr:id>034f6f958aa47e49cbb180fb10e1d728</gtr:id><gtr:otherNames>Chelban V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>58c7eec9b92e09.73733099</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FF06C3F8-182C-4837-93B8-CB831988ADC4</gtr:id><gtr:title>Pathological relationships involving iron and myelin may constitute a shared mechanism linking various rare and common brain diseases.</gtr:title><gtr:parentPublicationTitle>Rare diseases (Austin, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b7db88df9f44c9c37b5e7c23fe5b4135"><gtr:id>b7db88df9f44c9c37b5e7c23fe5b4135</gtr:id><gtr:otherNames>Heidari M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2167-5511</gtr:issn><gtr:outcomeId>58c7eec92aa0c7.66278096</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9839F0C3-8769-4498-A5DF-56205027AACF</gtr:id><gtr:title>The clinical and genetic heterogeneity of paroxysmal dyskinesias.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f9b6f09a6640fea0ca88338ba7ed5668"><gtr:id>f9b6f09a6640fea0ca88338ba7ed5668</gtr:id><gtr:otherNames>Gardiner AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>56a40966a7b457.83986332</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1B945271-FBAF-4286-ADFF-990B81BA8338</gtr:id><gtr:title>Mutations in GBA2 cause autosomal-recessive cerebellar ataxia with spasticity.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be4c0da55ab01c9f0e6393f9ed6fadce"><gtr:id>be4c0da55ab01c9f0e6393f9ed6fadce</gtr:id><gtr:otherNames>Hammer MB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>pm_15519_29_23332917</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5A3FAC5E-9561-4F32-BAD4-80D933CBB65C</gtr:id><gtr:title>Late-onset Lafora disease with prominent parkinsonism due to a rare mutation in EPM2A.</gtr:title><gtr:parentPublicationTitle>Neurology. Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6867986db8e51578e846cfba3cd72c66"><gtr:id>6867986db8e51578e846cfba3cd72c66</gtr:id><gtr:otherNames>Lynch DS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2376-7839</gtr:issn><gtr:outcomeId>58c7eec828ccf7.78367357</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>48B6EB36-C601-4B51-88DE-1ECC84CA8E91</gtr:id><gtr:title>Mutations in NKX6-2 Cause Progressive Spastic Ataxia and Hypomyelination.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/034f6f958aa47e49cbb180fb10e1d728"><gtr:id>034f6f958aa47e49cbb180fb10e1d728</gtr:id><gtr:otherNames>Chelban V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>5aa93ee97e6360.05809732</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D4139C33-17FB-4654-81C6-E6E371AA849A</gtr:id><gtr:title>Coenzyme Q10 Levels Are Decreased in the Cerebellum of Multiple-System Atrophy Patients.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ff2cda0ff39441e9d379b03cb269851"><gtr:id>3ff2cda0ff39441e9d379b03cb269851</gtr:id><gtr:otherNames>Schottlaender LV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>585d52e9b420e5.71535099</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A4772683-18D2-45BE-A8B8-B7E9C63CBD34</gtr:id><gtr:title>Multiple system atrophy and repeat expansions in C9orf72.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ff2cda0ff39441e9d379b03cb269851"><gtr:id>3ff2cda0ff39441e9d379b03cb269851</gtr:id><gtr:otherNames>Schottlaender LV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn><gtr:outcomeId>54629744015a89.26798603</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8E0BB020-B031-42D3-81F5-C19F5F123895</gtr:id><gtr:title>Mutations in the histone methyltransferase gene KMT2B cause complex early-onset dystonia.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0c984efdac34b58497e7b0f51d6d10eb"><gtr:id>0c984efdac34b58497e7b0f51d6d10eb</gtr:id><gtr:otherNames>Meyer E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>58c7eec300d1e8.51172808</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0BFCC9B8-99F0-4A2D-9882-9B32BC5666F7</gtr:id><gtr:title>Loss-of-Function Mutations in FRRS1L Lead to an Epileptic-Dyskinetic Encephalopathy.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7cbecc303d2e334d5905d7f14159341e"><gtr:id>7cbecc303d2e334d5905d7f14159341e</gtr:id><gtr:otherNames>Madeo M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>58c7eec54697a0.91691733</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DE4D0A31-2C40-4A93-9627-98877AF2A985</gtr:id><gtr:title>Mutations in noncoding regions ofare a major cause of X-linked CMT.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32eced6165160ce76ae4eaa88f46e3d0"><gtr:id>32eced6165160ce76ae4eaa88f46e3d0</gtr:id><gtr:otherNames>Tomaselli PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>58c7eec22d5770.85222790</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9DFD726E-5C06-48A3-BC71-1402975F3985</gtr:id><gtr:title>PKD or Not PKD: That is the question.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4aaa24babbcd19a7ca30f50b28b99d4e"><gtr:id>4aaa24babbcd19a7ca30f50b28b99d4e</gtr:id><gtr:otherNames>Balint B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>58c7eec8edab57.96583571</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>44369A19-D762-484F-9991-9C1FC8B5E41C</gtr:id><gtr:title>Reply: The p.Ser107Leu in BICD2 is a mutation 'hot spot' causing distal spinal muscular atrophy.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e200f814262dac4d6b88ac30584c047"><gtr:id>8e200f814262dac4d6b88ac30584c047</gtr:id><gtr:otherNames>Rossor AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>56a4096782a918.97249459</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D52CC8B5-0DFF-4F6F-B29C-A37910E39035</gtr:id><gtr:title>Novel single base-pair deletion in exon 1 of XK gene leading to McLeod syndrome with chorea, muscle wasting, peripheral neuropathy, acanthocytosis and haemolysis.</gtr:title><gtr:parentPublicationTitle>Journal of the neurological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f412cc6b7d29c6e9685797bea1d962d2"><gtr:id>f412cc6b7d29c6e9685797bea1d962d2</gtr:id><gtr:otherNames>Wiethoff S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-510X</gtr:issn><gtr:outcomeId>546297419ac958.95671858</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>812EDBDD-2F1F-414D-9EBB-3767CFA408F5</gtr:id><gtr:title>a-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson's disease and multiple system atrophy?</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8cf5553107e55c233b68c1efaf1db243"><gtr:id>8cf5553107e55c233b68c1efaf1db243</gtr:id><gtr:otherNames>Kiely AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>pm_15519_29_23404372</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4B4C5235-135A-4B1B-9DF6-7BD68EEF348B</gtr:id><gtr:title>Author response: A genome-wide association study in multiple system atrophy.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0a34ae6889d51d0636773dd2548e288e"><gtr:id>0a34ae6889d51d0636773dd2548e288e</gtr:id><gtr:otherNames>Scholz SW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>5aa93eeace4133.89132630</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CC10CEC0-1C26-44CF-A83D-26B790CA5486</gtr:id><gtr:title>A practical approach to diagnosing adult onset leukodystrophies.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf826f577934fec360780ebfe7e1b870"><gtr:id>cf826f577934fec360780ebfe7e1b870</gtr:id><gtr:otherNames>Ahmed RM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>54629740ad06a5.13382899</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BC80FC0D-4ECF-4AC2-B87D-D803996E97EF</gtr:id><gtr:title>Pantothenate kinase-associated neurodegeneration is not a synucleinopathy.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7c5c2253c4ba1d1ab5829aa152019a46"><gtr:id>7c5c2253c4ba1d1ab5829aa152019a46</gtr:id><gtr:otherNames>Li A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>pm_15519_29_22416811</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2DAB514C-1E4B-4B5C-8D36-37006C9DBEBD</gtr:id><gtr:title>Pathogenic VCP mutations induce mitochondrial uncoupling and reduced ATP levels.</gtr:title><gtr:parentPublicationTitle>Neuron</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fedc4404d626048147a389c1d14ecc32"><gtr:id>fedc4404d626048147a389c1d14ecc32</gtr:id><gtr:otherNames>Bartolome F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0896-6273</gtr:issn><gtr:outcomeId>pm_15519_29_23498975</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4A4AC2F5-EE82-4B72-AF98-54F4AB2EFB47</gtr:id><gtr:title>Characteristics of Unruptured Compared to Ruptured Intracranial Aneurysms: A Multicenter Case-Control Study.</gtr:title><gtr:parentPublicationTitle>Neurosurgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/91630dc25534e09c426f44e546f3e65c"><gtr:id>91630dc25534e09c426f44e546f3e65c</gtr:id><gtr:otherNames>Hostettler IC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0148-396X</gtr:issn><gtr:outcomeId>5aa93ee8329de4.53102184</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0F8112E9-AAE9-426D-B5CF-ABFFCCE16437</gtr:id><gtr:title>Hereditary leukoencephalopathy with axonal spheroids: a spectrum of phenotypes from CNS vasculitis to parkinsonism in an adult onset leukodystrophy series.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6867986db8e51578e846cfba3cd72c66"><gtr:id>6867986db8e51578e846cfba3cd72c66</gtr:id><gtr:otherNames>Lynch DS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>56a4096c135da9.29522020</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>52F4E22F-04BC-489B-BD98-D6B35D664443</gtr:id><gtr:title>Insights from cerebellar transcriptomic analysis into the pathogenesis of ataxia.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9960cd808582e52821f0e586e2ba9176"><gtr:id>9960cd808582e52821f0e586e2ba9176</gtr:id><gtr:otherNames>Bettencourt C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn><gtr:outcomeId>5462974283bc23.72125321</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F9082CA-2911-46C2-9B73-B4955ED9CD00</gtr:id><gtr:title>Genetic risk factors for intracranial aneurysms: a meta-analysis in more than 116,000 individuals.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e8073c0bd0f69cf5756d64d9d62fcdc"><gtr:id>8e8073c0bd0f69cf5756d64d9d62fcdc</gtr:id><gtr:otherNames>Alg VS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>pm_15519_29_23733552</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A5C53365-C8C5-4B01-AB8A-5A14428A7826</gtr:id><gtr:title>Validation of next-generation sequencing technologies in genetic diagnosis of dementia.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72f7fb44cb0e9d3dbae03fa9e859951a"><gtr:id>72f7fb44cb0e9d3dbae03fa9e859951a</gtr:id><gtr:otherNames>Beck J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>pm_15519_29_23998997</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>046ECAAC-0CDC-47F3-94C2-669C915FB3C0</gtr:id><gtr:title>Treatable childhood neuronopathy caused by mutations in riboflavin transporter RFVT2.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/79ba297a1edd6970078cb545704ad890"><gtr:id>79ba297a1edd6970078cb545704ad890</gtr:id><gtr:otherNames>Foley AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_540e168e1680c0b01</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E406D6A9-5B43-4A07-94FE-BE2B74154E64</gtr:id><gtr:title>Defects of mutant DNMT1 are linked to a spectrum of neurological disorders.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f0a851b1e66126a42944d2b038e10b89"><gtr:id>f0a851b1e66126a42944d2b038e10b89</gtr:id><gtr:otherNames>Baets J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>56a4096cd137c6.92269926</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AE9A6263-028F-45B9-BFCD-26D06BB2450B</gtr:id><gtr:title>C9orf72 expansions are the most common genetic cause of Huntington disease phenocopies.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/244cc363f830eda2f51ecf6bac87f6f0"><gtr:id>244cc363f830eda2f51ecf6bac87f6f0</gtr:id><gtr:otherNames>Hensman Moss DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>54629741286468.94539855</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A93C4DE2-4537-461B-8A28-FA38A3AA3C41</gtr:id><gtr:title>Kjellin syndrome: hereditary spastic paraplegia with pathognomonic macular appearance.</gtr:title><gtr:parentPublicationTitle>Practical neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3dab0e4563cc38ec8a53385853a2437b"><gtr:id>3dab0e4563cc38ec8a53385853a2437b</gtr:id><gtr:otherNames>Nowak VA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1474-7758</gtr:issn><gtr:outcomeId>54629742a8e222.00852509</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>322A7180-5428-4183-910D-247034F2F007</gtr:id><gtr:title>The pallidopyramidal syndromes: nosology, aetiology and pathogenesis.</gtr:title><gtr:parentPublicationTitle>Current opinion in neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/697536feebefd233256c0907479ff552"><gtr:id>697536feebefd233256c0907479ff552</gtr:id><gtr:otherNames>Kara E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1350-7540</gtr:issn><gtr:outcomeId>pm_15519_29_23817214</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A5ECD62A-46BA-45DF-80AF-62248A4286CA</gtr:id><gtr:title>Using human induced pluripotent stem cells to model cerebellar disease: hope and hype.</gtr:title><gtr:parentPublicationTitle>Journal of neurogenetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f412cc6b7d29c6e9685797bea1d962d2"><gtr:id>f412cc6b7d29c6e9685797bea1d962d2</gtr:id><gtr:otherNames>Wiethoff S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0167-7063</gtr:issn><gtr:outcomeId>56a4096b4492b0.58495591</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5121D49F-0DF1-42AC-A6DC-E1C103501FC1</gtr:id><gtr:title>What causes intracerebral bleeding after thrombolysis for acute ischaemic stroke? Recent insights into mechanisms and potential biomarkers.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4b03cc72ff363e8c8ae86303a127f41b"><gtr:id>4b03cc72ff363e8c8ae86303a127f41b</gtr:id><gtr:otherNames>Karaszewski B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>56a40968763867.14464972</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C77E47E8-AA82-4940-8D5C-2E7A7A39E226</gtr:id><gtr:title>Neuropathology of Beta-propeller protein associated neurodegeneration (BPAN): a new tauopathy.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b2ac56d4a5087705921cb2ad66bb2a3"><gtr:id>9b2ac56d4a5087705921cb2ad66bb2a3</gtr:id><gtr:otherNames>Paudel R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2051-5960</gtr:issn><gtr:outcomeId>56a4096b19f498.12889417</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0E56AB78-84CE-45A5-A9F9-6F760621EFD2</gtr:id><gtr:title>The 4H syndrome due to RNF216 mutation.</gtr:title><gtr:parentPublicationTitle>Parkinsonism &amp; related disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b7ff253acba98dc4017e32a051ce3e9"><gtr:id>6b7ff253acba98dc4017e32a051ce3e9</gtr:id><gtr:otherNames>Ganos C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1353-8020</gtr:issn><gtr:outcomeId>56a4096929de00.06116410</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4C6CEEF0-F838-41AE-AB03-305BBF8346C6</gtr:id><gtr:title>NDUFA4 mutations underlie dysfunction of a cytochrome c oxidase subunit linked to human neurological disease.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6459db0fb97de13ef30ce2614b06cb4a"><gtr:id>6459db0fb97de13ef30ce2614b06cb4a</gtr:id><gtr:otherNames>Pitceathly RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>pm_15519_29_23746447</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>57D3389C-6475-448E-9029-4D5A259B91DB</gtr:id><gtr:title>Phenotypic and molecular insights into spinal muscular atrophy due to mutations in BICD2.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e200f814262dac4d6b88ac30584c047"><gtr:id>8e200f814262dac4d6b88ac30584c047</gtr:id><gtr:otherNames>Rossor AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>56a4096d9d8c15.84685086</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2196F3BF-D184-4370-AAA1-4AF62E61B6E4</gtr:id><gtr:title>Mutations in ? adducin are associated with inherited cerebral palsy.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f031c0b2f78e03012bc542323de4d08"><gtr:id>1f031c0b2f78e03012bc542323de4d08</gtr:id><gtr:otherNames>Kruer MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>pm_15519_29_23836506</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6FC48D70-8EF7-4C23-AAFE-955ACA73A840</gtr:id><gtr:title>A novel TUBB4A mutation suggests that genotype-phenotype correlation of H-ABC syndrome needs to be revisited.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fc98b863ea1e6ac2e57978c77cd38ad6"><gtr:id>fc98b863ea1e6ac2e57978c77cd38ad6</gtr:id><gtr:otherNames>Erro R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>56a4096a5893b9.24399116</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4AC9645E-858B-414C-BC07-F76AC767181F</gtr:id><gtr:title>Genetic and phenotypic characterization of complex hereditary spastic paraplegia.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/697536feebefd233256c0907479ff552"><gtr:id>697536feebefd233256c0907479ff552</gtr:id><gtr:otherNames>Kara E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>58c7eec8c24b74.65858354</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C6BE95D5-6E82-47AF-B11D-46AD79702A6D</gtr:id><gtr:title>A 30-unit hexanucleotide repeat expansion in C9orf72 induces pathological lesions with dipeptide-repeat proteins and RNA foci, but not TDP-43 inclusions and clinical disease.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1a0840fa64698c2bea936eb7c3ca6bc7"><gtr:id>1a0840fa64698c2bea936eb7c3ca6bc7</gtr:id><gtr:otherNames>Gami P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>56a40967b7bf46.28979690</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>31E893A5-160F-4DD6-82B3-DB8285D838BD</gtr:id><gtr:title>The effects of an intronic polymorphism in TOMM40 and APOE genotypes in sporadic inclusion body myositis.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5740d7dfacf41317fd1190662cfe9c79"><gtr:id>5740d7dfacf41317fd1190662cfe9c79</gtr:id><gtr:otherNames>Gang Q</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>5675dfa36250f</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>91AB0EAD-34CB-4C2D-A08B-79A17A082813</gtr:id><gtr:title>A genome-wide association study in multiple system atrophy.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fc13094f3092b2a2f90b97002cd8eb10"><gtr:id>fc13094f3092b2a2f90b97002cd8eb10</gtr:id><gtr:otherNames>Sailer A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>58c7eec7bd0174.61165546</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>73D9DEB4-125B-4ADC-A47B-48D6C876FEDE</gtr:id><gtr:title>H-ABC syndrome and DYT4: Variable expressivity or pleiotropy of TUBB4 mutations?</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fc98b863ea1e6ac2e57978c77cd38ad6"><gtr:id>fc98b863ea1e6ac2e57978c77cd38ad6</gtr:id><gtr:otherNames>Erro R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>56a4096c710168.69605258</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>66B891DF-C3C8-4138-9AD3-B4B0572C4F05</gtr:id><gtr:title>Exome sequencing identifies a significant variant in methionyl-tRNA synthetase (MARS) in a family with late-onset CMT2.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/80583ad27ad24e91c0380658e597d61a"><gtr:id>80583ad27ad24e91c0380658e597d61a</gtr:id><gtr:otherNames>Gonzalez M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>pm_15519_29_23729695</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BE3882F6-AC70-42A1-9BCD-EE00D5B2D073</gtr:id><gtr:title>Polymyositis without Beneficial Response to Steroid Therapy: Should Miyoshi Myopathy be a Differential Diagnosis?</gtr:title><gtr:parentPublicationTitle>The American journal of case reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb7de9e0bdbda47bf81b86f2720f04e3"><gtr:id>bb7de9e0bdbda47bf81b86f2720f04e3</gtr:id><gtr:otherNames>Scalco RS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1941-5923</gtr:issn><gtr:outcomeId>58c7eec5ed6688.74304587</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FE8FF5D5-4213-4049-9722-3E33FA43EB51</gtr:id><gtr:title>PRUNE is crucial for normal brain development and mutated in microcephaly with neurodevelopmental impairment.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/008714e03cc79922a19d3b457141b891"><gtr:id>008714e03cc79922a19d3b457141b891</gtr:id><gtr:otherNames>Zollo M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>5aa93eea7a5a71.22024713</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ADFB1149-A862-485E-ADB0-DFD8801D09C1</gtr:id><gtr:title>Analysis of C9orf72 repeat expansions in a large series of clinically and pathologically diagnosed cases with atypical parkinsonism.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ff2cda0ff39441e9d379b03cb269851"><gtr:id>3ff2cda0ff39441e9d379b03cb269851</gtr:id><gtr:otherNames>Schottlaender LV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>546297449961a7.86208688</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A2D4F61F-8A8C-4757-A7E0-035036433F7C</gtr:id><gtr:title>A dominant mutation in FBXO38 causes distal spinal muscular atrophy with calf predominance.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f5c596058f4e99b11d3fe3dbd4f968f"><gtr:id>5f5c596058f4e99b11d3fe3dbd4f968f</gtr:id><gtr:otherNames>Sumner CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>54629740205172.11003535</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C24B4EF0-84CC-4943-94FE-400E72804DE0</gtr:id><gtr:title>Neuropathy target esterase impairments cause Oliver-McFarlane and Laurence-Moon syndromes.</gtr:title><gtr:parentPublicationTitle>Journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4721812e6d535c3d1145e4ec8237e968"><gtr:id>4721812e6d535c3d1145e4ec8237e968</gtr:id><gtr:otherNames>Hufnagel RB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-2593</gtr:issn><gtr:outcomeId>56a4096e17bf55.05066889</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13452B8E-C308-46BB-87A7-C03AAED84A1B</gtr:id><gtr:title>Cathepsin D deficiency causes juvenile-onset ataxia and distinctive muscle pathology.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/13a59fbd288093fca2ace1bf37b42241"><gtr:id>13a59fbd288093fca2ace1bf37b42241</gtr:id><gtr:otherNames>Hersheson J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>54629744764488.38556794</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>19096E5C-003F-44B1-BB66-42014707EB0D</gtr:id><gtr:title>Genome-wide estimate of the heritability of Multiple System Atrophy.</gtr:title><gtr:parentPublicationTitle>Parkinsonism &amp; related disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5bb0da6bb7eb8d81a012bd35afacacdc"><gtr:id>5bb0da6bb7eb8d81a012bd35afacacdc</gtr:id><gtr:otherNames>Federoff M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1353-8020</gtr:issn><gtr:outcomeId>56a40966495aa4.19373958</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3CB61841-FC4C-4E12-8276-51D358D854FE</gtr:id><gtr:title>Defects in the CAPN1 Gene Result in Alterations in Cerebellar Development and Cerebellar Ataxia in Mice and Humans.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52542eaf317f347220ec706e5b20b4a1"><gtr:id>52542eaf317f347220ec706e5b20b4a1</gtr:id><gtr:otherNames>Wang Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58c7eec952ad95.18955916</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B9AD0671-E6F8-4598-8815-C8C0FB5994B0</gtr:id><gtr:title>Genetics of neurodegenerative diseases: an overview.</gtr:title><gtr:parentPublicationTitle>Handbook of clinical neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7e018d848f37709256b024c30ea7824c"><gtr:id>7e018d848f37709256b024c30ea7824c</gtr:id><gtr:otherNames>Pihlstr?m L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0072-9752</gtr:issn><gtr:outcomeId>5aa93eeb282eb9.28217907</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AAAA5FE0-A72B-4517-8864-7C6FFAF3DAA5</gtr:id><gtr:title>Friedreich's ataxia and other hereditary ataxias in Greece: an 18-year perspective.</gtr:title><gtr:parentPublicationTitle>Journal of the neurological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a0141d4dc212d3dc1de00d97ceee75f7"><gtr:id>a0141d4dc212d3dc1de00d97ceee75f7</gtr:id><gtr:otherNames>Koutsis G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-510X</gtr:issn><gtr:outcomeId>54629740424d32.72626144</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F069AD07-A152-4723-B1EC-7C0ED0C9752F</gtr:id><gtr:title>A novel ABCD1 mutation detected by next generation sequencing in presumed hereditary spastic paraplegia: A 30-year diagnostic delay caused by misleading biochemical findings.</gtr:title><gtr:parentPublicationTitle>Journal of the neurological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a0141d4dc212d3dc1de00d97ceee75f7"><gtr:id>a0141d4dc212d3dc1de00d97ceee75f7</gtr:id><gtr:otherNames>Koutsis G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-510X</gtr:issn><gtr:outcomeId>56a40969f26c91.18516731</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>284E7C97-6B91-4C8C-91F9-6D07C4DE295E</gtr:id><gtr:title>Clinical features of childhood-onset paroxysmal kinesigenic dyskinesia with PRRT2 gene mutations.</gtr:title><gtr:parentPublicationTitle>Developmental medicine and child neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/961fb7c7b58bf324f312f76fae2f3a64"><gtr:id>961fb7c7b58bf324f312f76fae2f3a64</gtr:id><gtr:otherNames>Silveira-Moriyama L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0012-1622</gtr:issn><gtr:outcomeId>pm_15519_29_23363396</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FF937BEA-8FBA-4745-BAC3-475861A9189C</gtr:id><gtr:title>Diagnostic clues and manifesting carriers in fukutin-related protein (FKRP) limb-girdle muscular dystrophy.</gtr:title><gtr:parentPublicationTitle>Journal of the neurological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ff2cda0ff39441e9d379b03cb269851"><gtr:id>3ff2cda0ff39441e9d379b03cb269851</gtr:id><gtr:otherNames>Schottlaender LV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-510X</gtr:issn><gtr:outcomeId>56a4096e53c528.99196298</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/J004758/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>149FA87E-B8CD-4FFC-B515-EAD312BED03B</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Musculoskeletal</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>